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Abstract 
Lines selected high or low on lean body mass (P-Lines) or on carcass fat 
(F-Lines) for more than 30 generations were treated with recombinant bovine growth 
hormone (OH) to obtain information about the effects of selection on OH levels and 
responsiveness. All lines responded to OH with an increase in final body weight. In 
the lean mass selected lines the high line increased more than the low, but the 
increase relative to initial weight was similar in both lines (10-15%). OH did not 
have a significant effect on gonadal fat percentage. 
Further investigations involved the lean mass selected lines only. Weights were 
recorded on a daily basis from birth to weaning at 21 days, to investigate growth 
before mice become responsive to OH at 14 days. The high line had a mean litter size 
and approximately twice that of the low line, and a mean birth weight approximately 
50% greater than the low line. The difference in total litter weight at birth is greater 
(3 to 4 fold) than the difference in adult body weight (approximately 3 fold) 
suggesting that there may be between line differences in individual effects on in utero 
growth rates as well as differences due to maternal effects. Also an increase in the 
rate of gain was observed for both line at approximately 18 days of age. An increase 
was also observed in OH deficient little mice from the high P-Line, and hence 
is not due to OH. The increase in the rate of weight gain is greater in the wild type 
mice than in the little mice suggesting OH acts to magnify the effects of whatever 
causes the increase. 
Plasma OH levels were assayed, the high P-line had lower levels of OH at 4, 5, 
and 7 weeks of age then the low P-line. As IOF-I levels become GH inducible at 
about 14 days of age and the lines experience an increase in the rate of weight gain, 
which is greater in the high line than in the low line, at about 18 days it appeared 
possible that IOF-I levels differed between the lines. However IGF-I levels did not 
differ between the lines at 5 weeks of age, during the period of rapid growth 
PA, k, kF 
(S 	,, 1991). Hence IOF-I does not appear to be responsible for the 
differences between the high and low P-lines in growth rate. 
The little gene was backcrossed into both P-Lines and then little and wild type 
P-Line mice treated with OH. The dwarfs were approximately half the body weight 
of wild type mice from the same line. Little mice from both lines responded to the 
recombinant bovine OH with an increase in final body weight. The response was 
proportional to body weight, again suggesting that OH and responsiveness to OH 
have not been altered by selection. Preweaning weights of little mice were also 
recorded. 
Finally P-Line mice were treated with antiserum to OH. It appeared to reduce the 
rate of weight gain. The reduction in the high and low lines was proportional to body 
weight, and similar in magnitude to the increase induced by treatment with exogenous 
OH. This again suggests that OH is directly involved in the differences between the 
lines. 
In conclusion the proportionate effects of all attempts to manipulate OH levels 
indicate that growth hormone and responsiveness to OH are not directly responsible 
for the differences in growth rate and body weight between the P-Lines, although OH 
levels have been altered. Further investigation into the levels of OH mediators such 
as IOF-I, IOF-II, and the IOF binding proteins may be informative. Also, given the 
differences in birth weight, investigation of prenatal growth effects may be 
informative. 
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Chapter 1 
Introduction 
Several factors influence the profitability of livestock production for meat. These 
include how fast the animals reach slaughter weight, how much food they consume 
while growing, what proportion of the carcass can be sold and how healthy they are. 
These can be manipulated by a variety of means, selection of lines, and alteration of 
diet for example. As it is more feed efficient to lay down muscle than fat, producers 
will prefer leaner animals, providing the meat is not too lean for customer taste. 
In the wealthy 'First' world better nutrition and hygiene and, to a lesser extent, 
medicine have changed the principle causes of death from infectious diseases to 
non-infectious illness, for example cancer and heart disease (World Health 
Organisation, 1990). There is increasing evidence that some at least of these 
conditions are linked to diet. Indeed there are recommendations limiting the 
maximum daily intake of saturated fats, as high intakes of these are epidemiologically 
linked with high levels of cardiovascular disease and certain types of cancer (World 
Health Organisation 1990). Thus lean meat is preferred by consumers on health 
grounds, making lean animals more economically desirable. 
1.1 Selection 
Selection is a well established method of generating animals with particular 
characteristics. The effects are passed onto subsequent generations, and the process 
does not involve the treatment of animals with exogenous substances, which can 
arouse protest from consumers. Breeding experiments in farm animals are slow and 
expensive due to their size and long generation interval. Small mammals such as 
mice display many of the same traits, have a shorter generation interval, and require 
less space. Not being the same species only general conclusions can be drawn, but 
this is usually sufficient (Roberts, 1965). For example in mice recurrent selection 
(where selection is carried out in one line on the basis of the performance of progeny 
from a cross between that line and an inbred line), and reciprocal recurrent selection 
(where both parental lines are selected on the offspring of the cross) was less 
effective in altering body weight than mass or within family selection, obviating the 
need for costly experiments in farm animals (Roberts, 1965). 
One trait that has frequently been subject to selection is rate of growth. 
Differences in growth rates of pigs have been induced by selection (Baird, Nalbandov 
and Norton, 1952). Fast growing (Broiler) lines of chickens have been produced 
which have an adult weight more than twice that of unselected lines (Burke and 
Marks, 1982) or than lines selected for egg-laying ability (Stewart and Washburn, 
1983, Goddard, Wilkie and Dunn, 1988) . Many lines of mice differing in adult body 
weight or gain have been produced (McCarthy, 1982). Lines selected for high adult 
weight, or high post weaning gain can have an adult body weight which is two to 
three times that of a line selected for low weight (Timon and Eisen, 1969, Pidduck 
and Falconer, 1978, Sharp, Hill and Robertson, 1984). The divergence from the 
unselected control is usually assymetric on an arithmetic scale, with the increased 
body weight line showing a greater response than the decreased body weight line 
(McCarthy, 1982). Similar results have been obtained in the rat (Baker, Chapman 
and Wardell, 1975, O'Sullivan, Millard eta!, 1986). 
Selection on the rate of gain of weight over a particular age range, or on final 
weight has correlated effects on other production traits such as carcass fat and feed 
efficiency. These latter traits have also been subjected to selection, and correlated 
effects were noted on rate of gain and weight. Rats were selected on an index for the 
rate and efficiency of lean gain and divergence was found (Notter, Dickerson and 
Deshazer, 1976). The faster growing, more efficient animals ate more and were less 
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fat than the slower growing line (Rios, Nielsen, Dickerson and Deshazer, 1986). 
Selection on an index for increased lean mass in mice also resulted in greater feed 
efficiency (Bishop and Hill, 1985). Another study in mice showed that selection to 
increase any one of, feed intake, rate of gain or efficiency also increased the other 
traits (Sutherland, Biondini et al, 1970). This correlation suggests that to improve all 
these traits by selection the simplest method would be selection on rate of gain, as 
that only requires the recording of body weight at different times. Perhaps selection 
could be carried out on body weight which would be simpler still as it only requires 
one measurement. 
However work on selection on body weight at various ages in mice indicates that 
the age at which selection is carried out can affect the final weight, growth rate and 
fat composition in the selected lines (McCarthy and Bakker, 1979). For example 
analysis of the proportion of carcass fat at several ages in mice selected for increased 
weight at 5 and 10 weeks of age showed that selection at 5 weeks had no effect on 
carcass fat at any age. However selection at 10 weeks resulted in lower fat deposition 
at all ages analysed (Hayes and McCarthy, 1976). 
c..r C 
Fat and lean percentagesnegatively correlated and at least one study has indicated 
that selection for high fat percentage may have the same effects on carcass 
composition as selection for low lean percentage at the same age, and vice versa 
(Prasetyo and Eisen, 1989). This differs from earlier work in which lines were 
selected for high or low carcass fat (estimated as 8 times gonadal fat pad weight) or 
on an index which estimated lean mass. The lines selected on lean mass differed little 
in carcass composition, unlike the fat lines which had a two to three fold difference in 
fat, but little in lean mass (Bishop and Hill, 1985). The difference between the results 
of the studies may be due to selecting on lean or fat mass, as opposed to lean or fat 
percentage. 
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It would appear that selection can produce substantial alterations in the desired 
trait providing the appropriate selection point and criterion are chosen. However 
selection is a long term project, and may have disadvantages, for example there. is 
evidence of infertility in lines of mice selected for long periods for high body weight 
(McCarthy, 1982). Investigation has also proceeded into methods of altering rates of 
gain and carcass composition with more immediate effects. These include attempts to 
manipulate levels of growth hormone (GH), which is necessary for normal growth 
(Phillips, 1987). 
1.2 The growth hormone axis 
The control of GH levels in the plasma is complex, and, while the general pattern 
is similar across a range of mammalian species, details vary. Growth hormone is 
produced in the anterior pituitary and released into the blood (Karin, Castrillo and 
Theill, 1990). Transcription of the OH gene, and release of OH from somatotrophs is 
increased by thyroid hormone, glucocorticoids and OH-releasing Factor (OHRF) 
(Phillips, 1987). Indeed in some species normal development of somatotrophs is 
dependent on GHRF (Karin et al, 1990). Release is inhibited by somatostatin, which 
is produced by the hypothalamus (Brazeau, Vale, et al, 1973). Somatostatin and 
OHRF levels appear to be affected by plasma levels of GH and IOF-1 and by 
environmental stimuli. 
Plasma GH levels vary over the long and the short term. OH secretion differs 
between the sexes in both periodicity and concentration. In males OH secretion 
shows more pronounced and regular (every three hours in rats) but less frequent 
peaks than in females, which have lower levels of OH both at peak and trough (Eden, 
Jansson, and Oscarsson, 1987). Periodicity appears to be influenced by the steroid 
sex hormones (Eden et a!, 1987). These hormones also act to increase OH secretion 
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(Reeds, 1987). Injection of GB into females so as to mimic male secretory patterns 
results in greater growth than injections which reproduce female patterns (Robinson 
and Clark, 1987). Also plasma levels of GH rise during sleep (Phillips, 1987). These 
effects are in addition to the changes in GH secretion during development (Slabaugh, 
Leiberman, Rutledge and Gorski, 1982). 
Mediation of growth hormone effects is equally complex. Growth hormone is 
necessary, but not sufficient, for normal growth and development as some forms of 
dwarfism exist in which GH is produced, and treatment with exogenous GB is 
ineffective (Phillips, 1987). Also GH treatment of 
thyroidectomised-hypophysectomised rats induced skeletal and muscle growth, but 
thyroxine was necessary for maturation, for example for closure of the epiphyses. 
Thyroxine appeared to have some growth promoting effects, but primarily acted to 
induce differentiation of the cells resulting from the increased rate of division induced 
by GB (Scow, Simpson et a!, 1949, Scow, 1959). The effects on growth may also be 
site specific: in human males suffering from growth hormone deficiency, treatment 
with GH during puberty increased standing height, but not sitting height, implying 
that GB affected mainly growth of the long bones of the legs (Tanner, Whitehouse, 
Hughes and Carter, 1976). 
Growth hormone binds to receptor sites on many tissues, including adipose cells. 
Displacement experiments on rat adipocytes using radioactive GB showed that it has 
its own, specific receptors on these cells (Grichting, Levy and Goodman, 1983). 
Earlier studies had suggested this (Fagin, Lackey, Reagan, and Di-Girolamo, 1980, 
Gavin, Saitman and Tollefsen, 1982). The existence of such receptors strongly 
suggests that GH acts directly on rat adipocytes. GH rarely affected fresh adipocytes 
from normal rats, but did those from hypophysectonñsed rats. This suggested that the 
lack of response was not primarily a consequence of cell surface damage occurring 
during the isolation of the adipocytes, but was at least partly due to the GH levels in 
the pre-excision environment. It was found that culturing adipocytes from normal 
rats in GH free medium for 3-4 hours caused them to become responsive to Gil 
(Herington, Stevenson, and Andrew, 1985). Similar treatment did not induce 
responsiveness in rabbit adipose tissue segments or isolated adipocytes (Richter and 
Schwandt, 1985, Barenton, Batifol et al, 1989). A study on rat and sheep adipose 
tissues showed that GM increased lipolysis in the rat tissue, but not in sheep tissue. 
Both were lipolytically competent and demonstrated 3-agonist induced lipolysis. 
Anti-GH immunoglobulins blocked the response of the rat tissue (Duquette, Scanes 
and Muir, 1984). This suggests species specific differences. 
Puromycin, which blocks protein synthesis, does not affect the increase in free 
fatty acid release induced in adipocytes by GH (Dawson and Beck, 1965). This 
suggests that GH does not induce this release by increasing enzyme production. 
Grichting, Levy and Goodman, (1983) observed that GH stimulated glucose 
utilization, and induced refractoriness in adipose cells. It also antagonised the 
lipolytic activity of adrenaline. GM treatment of adipose tissue of 
hypophysectomised rats increased glucose oxidation in the short term and lipolysis in 
the long term (Goodman, 1984). Earlier work had shown that a chronic high dose of 
GH reduced fat storage and the synthetic ability of adipose tissue in 
hypophysectomised rats (Goodman, 1963). However adipocytes from GM deficient 
little mice which had been given short term or chronic treatment with GH showed a 
reduction in fatty acid synthesis regardless of length of treatment (Ng, Adamafio and 
Graystone, 1990). This may reflect differences in other pituitary hormones, as the 
little mutants appear to only lack GH, unlike hypophysectomised mice. Some of the 
difference between long and short term effects on adipocytes of GH treatment may be 
due to modification of the GM receptors which are rapidly taken into the cell after 
binding, and have to be resynthesised (Gorin and Goodman, 1985). In pigs at least 
the long term insulin antagonist effects do not appear to be due to decreases in insulin 
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binding or insulin receptor kinase activity (Magri, Adamo, Leroith and Etherton, 
1990). 
The liver and cartilage release insulin-like growth factor (JOE) into the plasma in 
response to OH stimulation (Phillips, 1987). It is thought that these and other tissues 
also produce locally acting IOFs in response to OH exposure (Bomboy and Salmon, 
1975, Etherton,' 1 989). Evidence for the induction of JGF-J release by GH stimulation 
includes work showing that injection of exogenous OH increases IGF-I levels in two 
different stains of pigs (Owens, Johnson, Campbell and Ballard, 1990). Also 
inhibition of GH levels in the neonatal rat by an antiserum to rat OH lead to a 
reduction in circulating levels of IGF-I (Flint and Gardner, 1989, Gardner and Hint, 
1990). Further evidences that IGF-I mediates the effects of OH on growth are that 
injection of IGF-I induced growth in growth hormone deficient mice (Woodall, 
Breier, O'Sullivan, and Gluckman, 1991) and that measurements of IGF-I levels in 
transgenic mice with high levels of GH show that high growth occurs only after IGF-I 
levels have become OH inducible (Mathews, Hammer, Brinster and Palmiter, 1988). 
Similarly mice transgenic both for OH-diphtheria toxin (which is only expressed in 
somatotrophs and kills cells which express it) and for Metallothionien-IGF-I express 
IGF-I and grow normally. Mice transgenic for the toxin alone are dwarfs (D'Ercole, 
1990). Further reinforcement is given by the effects of the frequency of IGF-I 
injections. IGF- 1 had a greater effect on growth if four injections were given in 24 
hours, rather than if one or two were, which is similar to the effects of the frequency 
of OH injection (Woodall a al, 1991). 
Not only do JOE-I and thyroxine appear to mediate growth hormone's effects on 
growth them is evidence that insulin and OH may interactively modify fat 
metabolism. In hypophysectomised rats, which have very low insulin levels, adding 
glucose to the diet, or injecting the animals with insulin increased adipose tissue 
responsiveness to OH (Gause, Eden, Jansson and Isaksson, 1983, Gause, Jsaksson, 
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Lindahi, and Eden, 1985). The maintenance of fatty acid synthesis by insulin in 
sheep adipose tissue slices and cell cultures was blocked by growth hormone 
(Vernon, 1982). In rats injection of Anti-GH immunoglobulins shortly before 
excision of the fat pad did not affect insulin binding. It did alter the dose-response 
curve for insulin (Schwartz and Eden, 1985). This suggests that OH alters post 
receptor responses to insulin. OH also blocked insulin-induced increases in lactation 
levels in sheep (Vernon and Finley, 1986). In mutant little mice, which lack OH, 
acute OH treatment had insulin - like activities, chronic treatment had insulin 
antagonist effects (Ng and Veis, 1990). Again complex interactions were occurring 
between OH and another hormone. 
There is evidence that the effects of OH on fat metabolism are, at least in part, 
controlled by post translational modification of the protein (Reeds, 1987). In rats, 
recombinant bovine OH (bGH) had lower lipolytic and insulin antagonising activities 
than pituitary bGH in vitro, while theft effects were virtually indistinguishable in vivo 
(Hart, Chadwick et al, 1984). Also two electrophoretic fractions of pure pituitary 
derived growth hormone were equally effective in vivo, but not in vitro (Salaman 
1972). These differences may have been the result of contamination but it has been 
shown that a bacterially produced OH was more lipolytically active in vitro after a 
limited protease treatment (Baumann, Eisemann, and Currie, 1982). Also the 
secretory pattern of OH has measurable effects on growth, at least in the rat 
(Robinson and Clark, 1987). Despite uncertainties as to its precise mode of action 
OH has a clear effect in decreasing fat percentage and increasing efficiency of gain. 
This makes treatment with exogenous OH potentially valuable for commercial use. 
Also it is apparent that there are several points at which manipulation of the growth 
hormone axis could be attempted. Such manipulation could involve treatment with 
exogenous hormone, selection on levels of a hormone, or production of transgenic 
animals, for example. 
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1.3 Effects of growth hormone manipulation on production traits 
Production traits are those traits which affect the profitability of animal 
production. These include rate of increase of body weight, mature body weight, feed 
efficiency and carcass fat percentage. Manipulation of the growth hormone axis 
would only be useful if it affects some or all of these, and improves profitability. 
1.3.1 Injection of exogenous Growth Hormone 
Injection of exogenous growth hormone has been studied in a variety of species. 
In four studies in pigs it was found that GH increased growth rate and feed efficiency 
when injected, whether porcine (Chung, Etherton, and Wiggins, 1985, Evock, 
Etherton, Chang and Ivy, 1988, Mclaren, Easter,et al, 1988) or human growth 
hormone was used (Baile, Della-Fera, and McLaughlin, 1983). The study using 
human growth hormone found no significant effects on carcass quality (assessed as 
the product of several traits including composition and muscle tenderness) (Baile a 
al, 1983). In contrast, with porcine GH fat percentage decreased and muscle area 
increased regardless of whether recombinant or pituitary GH was used (Evock a al, 
1988). Fat percentage was reduced even when weight of fat in the carcass was not, 
due to increased lean mass (Chung a al, 1985). Similarly, in another study using 
porcine GH a considerable effect on carcass composition was observed (Novakofski, 
McKeith a al, 1988). The difference may be due to the differences in growth 
hormone or it may be due to other factors, such as diet. 
Several workers have observed decreased fat percentage and improved muscle 
mass in lambs after administering GH (Wagner and Veenhuizen, 1978, Muir, Wien a 
a!, 1983, Johnsson, Hart, Butler-Hogg, 1985, Butler-Hogg and Johnsson, 1987, 
Johnsson, Hathom a al, 1987). There was little or no effect on absolute weight. 
Others have found no significant effects (Sinnet-Smith a al, 1989). One study, on 
intact male lambs, rather than females or castrates, did note significant differences in 
body weight, and the rate of increase of body weight (Pullar, Johnsson and Chadwick, 
1986). This may indicate a sex difference in response. The varied results of these 
studies were reflected by another which showed equivocal effects on growth (Pell, 
Blake et al, 1987). GH increased the rate of synthesis of mRNA in muscle, and the 
efficiency of protein production, hence the rate of protein synthesis increased (Pell 
and Bates, 1987), as was implied by an earlier study which showed that OH increased 
nitrogen retention (Davis, Garrigus and Hinds, 1970). Protein accumulation was 
specific to the muscles, in cartilage there was increased synthesis and breakdown 
(Pell and Bates, 1987). The general increase in muscle mass found in sheep, and 
similar results in pigs (Chung et al, 1985) indicate that the weight of carcass fat is not 
necessarily decreased by Gil treatment, muscle weight increases, and carcass fat 
percentage consequently declines. In sheep, unlike pigs, GH does not generally 
increase feed efficiency as, although an increase was noted in one study (Johnsson, a 
al, 1985), it was not apparent in a later one (Johnsson, Hathorn, et a!, 1987). Also 
Butler-Hogg and Johnsson (1987), and Johnsson, Hathorn a a! (1987) both showed 
that GH increased non-carcass components such as wool. 
In hypophysectornised rats, exogenous growth hormone increased growth by 
increasing anabolism, without affecting catabolism. In contrast, work-induced 
hypertrophy acted by also reducing catabolism. These processes affected the two 
muscle fiber types in different ways, and the resulting muscles had disparate fiber 
compositions (Goldberg, 1969). In intact rats a study showed that exogenous GH did 
not appear to effect muscle growth by increasing satellite cell proliferation and 
myonuclei accumulation (Beerman, Liboff, Wilson, and Hood, 1983). Long term 
administration of GH to lambs increased muscle RNA and activity per unit of RNA. 
Protein synthesis also increased, more so in red muscle than white, for a given gain 
10 
(Pell and Bates, 1987). GH in fed lambs increased nitrogen retention. This, with 
accompanying alterations in other traits, suggested increased protein production 
(Davis a al, 1970). In contrast a study in fasting lambs showed that GH reduced 
protein synthesis (Crompton and Lomax, 1987). Other studies have shown that OH 
in fasting ruminants acts to maintain protein gain (Hart and Johnsson, 1986). It is 
generally accepted that GH acts, directly or indirectly, to increase protein synthesis 
(Hart and Johnsson, 1986). 
As well as its effects on meat production, emphasised by Goodman and Grichting 
(1983), and Reeds (1987), OH has been shown to increase the efficiency of milk 
production (Baumann a al, 1982). Indeed three breeds of cattle all had increased 
milk and fat yields when treated with recombinant bGH, with no breed by treatment 
interaction effects (Oldenbroek, Garssen, Forbes and Jonker, 1989). 
The sequence of OH is highly conserved across mammals and it has been shown 
that injection of foreign OH can induce an increased rate of gain in many species, for 
example human growth hormone into rats (Baile a al, 1983), and bovine OH into 
lambs (Johnsson a al, 1985, Johnsson, et al, 1987). This cross reactivity is not 
universal, humans appear to respond only to human OH (Phillips, 1987), 
consequently experimentation may be needed to identify a OH which is active in the 
species being investigated. 
Although GH treatment appears promising it may not always be effective, if only 
because treatment could lead to down regulation of endogenous OH levels. 
Exogenous OH has been shown to reduce the plasma levels of endogenous GH and 
the number of somatotrophs in the pituitary in pigs (Chung a al, 1985). Similarly, 
OH-Metallothionien transgenic mice completely lacked somatotrophs and pituitary 
OH production (Palmiter, Norstedt a al, 1983). 
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1.3.2 Immunoneutralization 
Growth hormone levels have been manipulated by injection of animals with 
antibodies to growth hormone. Such treatment reduces growth in young postweaning 
rats (Gause et al, 1983) and in neonatal rats (Flint and Gardner, 1989). Despite the 
effects of GH in increasing milk yield (Baumann a a!, 1982) injection of antiserum to 
rat GH into nursing rats did not reduce lactation (Madon, Ensor, Knight and Flint, 
1986). Removing prolactin reduced milk yield to approximately 50 percent, and then 
treatment with anti-rat GH completely blocked milk yield (Madon, a al, 1986). This 
suggests that although GH elicits some milk production, possibly by binding to 
prolactin receptors, the increase in yield produced by GH treatment may be due 
primarily to alterations in repartitioning, making more energy available for milk 
production. Reduction of growth hormone levels is unlikely to be commercially 
viable, although it may be useful to minimise adverse side effects of high GH levels, 
such as infertility, in breeding stock. For such a purpose it would be preferable to 
find a long lasting treatment. It may be of interest that some rats show a long term 
reduction in rate of gain after treatment with anti-rat GH (Gardner and Flint, 1990). 
However this appears to be due to some rats mounting an inadequate immune 
response to the antiserum to the GH, and may not be practicable to reproduce 
(Madon, Parton and Flint, 1991). Improvement of growth by treatment with 
antiserum to somatostatin seems a reasonable prospect as such treatment has been 
shown to increase GH levels (Ferland, Labrie, a a!, 1976) 
1.3.3 Production of Transgenics 
It has been clearly shown that the introduction of growth hormone genes into 
fertilised eggs by microinjection can produce larger animals, up to twice the size in 
mice (Palmiter, Brinster et a!, 1982). The improvement is passed on to the offspring 
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(Palniiter et al, 1983). These results are comparable to those obtainable by selection, 
but were effectively obtained in a single generation. This would suggest that the 
production of transgenic animals might be a major innovation, if the method can be 
repeated in meat producing animals. Transgenic rabbits, sheep , pigs (Hammer, 
Pursel et a!, 1985) have been produced, as well as cows, (Hammer et a!, 1986). Not 
all those which incorporated growth hormone genes were larger than their 
non-transgenic litter mates. This depended in part on the site of insertion, some 
inserted genes were inserted into an inactive part of the chromosome, and in part on 
the promoter used. Pigs carrying a prolactin-Growth hormone gene construct were 
only larger than their wild type litteimates if given prolactin inducers (Polge, Barton 
et al, 1989). On the other hand pigs with a metallothionien-GH construct grew faster 
with just the normal dietary levels of zinc as inducer (Hammer et al, 1985). The 
quality of the diet may also be important, GH transgenic pigs showed increased daily 
gain when given protein supplements, but did not on the normal diet (Pursel, Pinkert 
et a!, 1989). 
Gil transgenic animals have a greater final weight than non transgenics of similar 
background. This seems to be due to an increased growth rate. In mice the period of 
rapid growth is of similar length in wild type and in transgenics, but transgenics grow 
faster (Brem, Wanke et al, 1989). Transgenic animals also differ from wild type mice 
in body composition. Dwarf little mice transgenic for Gil were similar in size to, or 
larger than, non-transgenic wild type mice of similar genetic background, but body 
proportions were not restored to normal (Hammer, Palmiter and Brinster, 1984). 
Mice selected for high eight week body weight were similar in size to those 
transgenic for GH. When compared to unselected control animals, transgenics had 
longer bones than the controls, whereas the selected animals did not. However 
control animals had longer bones than transgenic or selected animals when the 
comparison was of bone length relative to the cube root of maximum body mass 
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(Wolf, Rapp et al, 1991). Earlier work indicated that liver weight was a greater 
fraction of body weight in transgenics than in controls (Brem et a!, 1989). Clearly 
GH does not just increase all growth. 
OH transgenics tend to have reduced fertility and mobility (Jaenisch, 1988). Even 
mutant little mice, which lack endogenous OH production, suffer a reduction in 
female fertility when made transgenic for metallothionien-GH constructs (Hammer a 
al, 1984). Ovary transplants between OH transgenic mice and non transgenic litter 
mates showed that ovaries from transgenic mice produced normal eggs in a normal 
physiological environment. Ovaries from non transgenic mice did not function in 
transgenic females (Brem a al, 1989). This suggests that the excessive plasma levels 
of OH are interfering with ovulation. This is supported by investigation of hormone 
levels in female mice transgenic for OH. The transgenics were less responsive to 
gonadotrophin releasing hormone than the controls, and were also 
hypoprolactinaeniic. The latter may be due to the effects of OH in mimicking 
prolactin, and down regulating its secretion (Chandrashekar, Bartke and Wagner, 
1990). 
The mobility and other health problems may also be a function of excess OH, as 
injection of high levels of exogenous OH resulted in reduced mobility and in 
osteochonclrosis in pigs (Evock et al, 1988) and caused kidney and liver degeneration, 
also in pigs (Machlin, 1972). Comparisons have been made of mice transgenic for 
growth hormone releasing factor (ORF), OH, and IGF-I. The first two groups have 
high OH levels, the latter does not. Animals with high GH levels showed progressive 
glomerulosclerosis, similar to that observed in human diabetics. Transgenics for 
IOF-I had enlarged glomeruli but no sclerosis, suggesting growth inducing effects of 
IGF-I on the glomeruli (Doi, Striker et a!, 1988). Also high OH levels were 
associated with high blood cholesterol and an enlarged liver (Quaife, Mathews a al, 
1989). Some health effects such as abnormal skin development and high serum 
triglycerides were found in all three groups (Quaife et al, 1989). These suggest that it 
may be possible to avoid some health problems by altering parts of the GH axis other 
than Gil. The growth increase of transgenics over controls may be smaller, but if 
fertility and health are maintained the animals may be more efficient than Gil 
transgenics. 
Alternatively consideration may be given to blocking production of one of the 
down regulators of the GH axis, It is possible to block hormone production by use of 
trausgenics, GH levels have been reduced by ablation of GH producing cells either by 
the insertion of a GH-Diphtheria toxin construct (Behringer, Mathews, Palmiter and 
Brinster, 1988), or by use of a GH-herpes virus thymidine kinase construct. It may be 
possible to use such a technique to block, say, somatostatin production. 
Another consideration with transgenic mice is the efficiency of transmission of 
the improvement to their offspring. Transmission from founder animals expressing 
the transgene to their offspring ranges from 0 to 50 percent, depending on what 
fraction of the germ line carries the gene (Hammer et al, 1986). Then the offspring 
may be infertile. However once past the first generation rates of transmission within a 
line are usually close to fifty percent (Hammer et al, 1986). However a study on the 
effects of crossing of mice transgenic for rat GH with a line not congenic with their 
background strain found that the frequency of the transgene in the population 
dropped. This happened even in a line which was selected for high 42 day body 
weight after the initial cross, despite transgenic mice being significantly heavier at 
that age than non-transgenics (Sabour, Ramsey and Nagai, 1991). This suggests that 
the change in genetic background caused the transgene to become unstable in the 
population, possibly by increasing the infertility or death rates in the transgenics. 
This could be a disadvantage if crossing a Gil transgene into commercial strains. It is 
also possible that animals homozygous for the transgene could be produced, if the 
problem of female infertility is solved. In mice such animals were produced after 
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ovary transfer. The animals homozygous for the GH transgene had more than twice 
the basal plasma levels of OH of the hemizygous animals. There was also a two fold 
or greater difference in inducible OH (Yun, Li a al, 1990). If this resulted in a 
comparable increase in growth, but not in health problems, such homozygous animals 
could be valuable. 
1.4 Changes in the growth hormone axis and growth after selection. 
There is considerable data to show that selection on growth rate or final weight 
can affect growth hormone levels. Growth hormone differences between genetically 
large and small rats were correlated with growth, with large animals having 
significantly higher peak and basal plasma OH concentrations than the small ones 
(O'Sullivan a a!, 1986). Similarly comparison of two lines of Hampshire swine, one 
fast gaining, one slow, showed that the faster line had a larger pituitary. This line 
also had more GH activity per unit weight of dried pituitary, suggesting more GH 
secretion (Baird a a!, 1952). There is also evidence that larger breeds of cattle have 
increased levels of OH (Hart and Johnsson, 1986). However work in which the Snell 
Dwarf gene, was backcrossed into strains of mice selected for large and small size, 
thereby depleting them of endogenous OH, showed that OH secretion was only 
partially responsible for differences in growth rate and that the smaller mice had 
reduced sensitivity to OH (Pidduck and Falconer, 1978). 
The correlation between components of the growth hormone axis can be altered 
by selection. Mice expressing a major gene for high growth rate have lower levels of 
OH but higher levels of IGF-I than unselected controls, this may indicate IOF-I levels 
influence the down regulation of OH levels (Medrano, Pomp a a!, 1989). A similar 
reduction in OH levels associated with growth has also been observed in chickens, 
broiler lines of chickens selected for faster growth rate have lower plasma levels of 
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GH than slower growing layer lines (Burke and Marks, 1982). Three broiler strains 
differing in growth rate also showed a negative correlation between growth rate and 
OH levels, although high OH levels reduced carcass fat (Stewart and Washburn, 
1983). This may be due to an alteration in the induction of IGF-I, as appears to be the 
case in the mice. However IGF-I need not be affected, lines of mice divergently 
selected for high or low protein or fat body mass ratios did not differ in circulating 
IGF-I levels at 5 weeks of age, during a period of rapid growth. The high body 
weight line did have significantly higher plasma concentrations of IGF-I at 10 weeks 
of age (McKnight and Goddard, 1989). Similarly other lines of broiler chickens 
which showed reduced plasma GH levels showed no difference in IGF-I levels 
(Goddard a al, 1988). Selection has also been carried out on plasma concentrations 
of IGF-I. Correlated differences in size were obtained, although the differences were 
less than those obtainable by direct selection on body weight (Blair, McCutcheon a 
al, 1989). 
In general studies in a variety of species indicate that the relationship, within 
species, between endogenous levels of growth hormone and several growth 
parameters is poor (Hart and Johnsson 1986). There is also the problem of the 
pulsatility of release which appears to influence effects on growth, at least for OH 
(Eden a al, 1987) and IGF-I (Woodall a al, 1991). Such factors would tend to 
reduce the efficiency of selection on components of the OH axis. The components 
also need not diverge in a correlated manner, as shown by lines of mice in which the 
high body weight line has higher IGF-I and lower OH levels than unselected controls 
(Medrano a al, 1989). In addition there is evidence for differences in OH sequence, 
different restriction fragment length polymorphisms were fixed in a line selected for 
high body weight and in unselected controls (Salmon, Berg, Yeb and Hodgetts, 
1988). In a backcrossing experiment the haplotype fixed in the high line was 
associated with low 42 day body weight however, which suggests the effect of this 
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haplotype may be specific to the genetic background (Winkelman, Querengesser and 
Hodgetts, 1990). This suggestion was supported by further selection on body weight, 
using the F2 from the backcross as the base population, which increased the 
frequency of this haplotype in lines selected for high body weight, and decreased it in 
lines selected for low body weight (Winkelman and Hodgetts, 1992). Also other 
hormones or enzymes may be affected, broiler lines of chickens have up to 20 times 
the levels of ornithine decarboxylase levels in breast muscle as layers (Bulfield, 
Isaacson and Middleton, 1988). The system is complex, and assays expensive, which 
suggest that, for the moment at least, selection is best carried out on physical traits 
such as weight. The differences in components of the GH axis also suggest that 
responses to exogenous treatments, such as GH injection, may also differ between 
selected lines, with some not responding at all. Investigation of such differences 
could give useful information as to differing ways of managing different strains. 
1.5 Justification 
Growth and fat control are complex and need further investigation. I am 
interested in the involvement of growth hormone on both these traits, in particular 
how selection on either trait alters the growth hormone axis. Several possible sites of 
alteration exist, for example, plasma GH levels, responsiveness to Gil or changes in 
the activity of Gil due to sequence alterations. There is no reason to assume that only 
one of these potential alterations has occurred or been selected for during the 
selection process. 
Lines of mice selected from the same base population which differ two to three 
fold in lean mass with no change in fat content or two to three fold in carcass fat with 
no change in lean mass (Bishop and Hill, 1985) were available. These have not been 
investigated for differences in growth hormone levels, activity, or responsiveness. 
Such investigation could throw light on the differences between the lines in question, 
and would add to the information on the growth hormone system. 
1.6 Animals 
The mice used throughout the experimental work were taken or derived from the 
F and P lines of mice maintained at the University of Edinburgh, Genetics mouse 
house. The background of the lines is included in the introduction because they are 
of such importance to the thesis. 
The F and P line mice were taken from selected lines which descended from a 
common base population, the 'U' strain. This was established in 1980 (Sharp et al, 
1984). Two inbred lines, JU and CBA were crossed and the Fl crossed to the outbred 
strain CFPL, which was obtained from the Carnworth laboratory in 1976. There 
followed one generation of random mating, the next being generation 0 of the 
selection experiment (Sharp et a!, 1984). Three replicates of each direction, high, low 
and control of the selection criteria were established. Selection was applied within 
family on 10 week old males. The F-Line was selected on the ratio of gonadal fat pad 
weight to body weight, the P-Line on an index (body weight (g -[8 x gonadal fat pad 
weight])) which was a predictor of fat free mass (Sharp et a!, 1984). 
In generation 20 the selection criteria were modified such that the P-Lines were 
selected on 10 week weight in both sexes and the F-Lines were selected on the ratio 
of dry to wet weight in 14 week old males. The three replicates of each direction were 
crossed at this stage to give new, unreplicated, lines with lower inbreeding. The 
generation interval was also increased from 12 to 15 weeks, for ease of management. 
The P-Lines differed two to three fold in lean mass, but little in carcass composition 
(Bishop and Hill, 1985). The F-lines differed two to three fold in carcass fat 
percentage but little in lean mass (Bishop and Hill, 1985). This divergence in carcass 
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fat was maintained even after the selection index was changed to the ratio of dry 
weight to body weight instead of gonadal fat pad (Hastings and Hill, 1989). 
Litters were culled to a maximum of 12. Care was taken to leave as near as 
possible to equal numbers of males and females. The mice were fed B.P. expanded 
mouse diet number one food ad libitum, with the same food available as mash around 
weaning if required. The presence of mash ensures that even small mice have access 
to food and water. Pregnant and nursing females of the F and P Lines received 
number 3 food ad libitum. Number 1 food contains 14.8 MJ/ Kg gross energy and 
14.6 % by weight crude protein, number 3 contains 15.4 MJ/ Kg gross energy and 
22.7 % crude protein (Manufacturers specifications). The temperature in the animal 
house was maintained at above 20 Celsius. Stock and breeding animals were not kept 
in a controlled light environment and were exposed to normal light period variation 
for this latitude. 
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Chapter 2 
Preliminary Trial of Growth Hormone 
2.1 Introduction 
It seems plausible, given the known effects of GH on growth and composition 
that GH is involved in the differences between the high and low body weight P-Lines, 
and in the differences between the fat and lean F-Lines. One line of investigation is 
to study the different responses of the lines to exogenous OH. If sensitivity, 
measured as proportional increases in growth, had altered, the existence of a 
difference in the number of receptors could be inferred. It is also possible that a 
given tissue, for example fat or liver, would be more affected in one line than another, 
suggesting changes in the metabolic control mechanisms. 
Males and females have different mature weights and growth rates, which seem to 
be linked to differences in the pattern of pulsatile release of growth hormone (GH) 
(Robinson and Clark, 1987). This suggests that the sexes would differ, at least 
quantitively, in their response to injected GH. However in transgenic mice males and 
females usually have similar mature weights and growth rates (Hammer a cii, 1986) 
in response to high plasma levels of GH. In transgenic animals OH levels are 
continuously high, which is not the case in injected animals (Robinson and Clark, 
1987). Only one sex was used in the experiments, removing a potential source of 
variability. 
2.2 Materials and Methods 
F-Line mice were assigned randomly within family to a treatment group after 
weaning at 3 weeks of age. They were transferred to a controlled light room, 14 
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hours light, 10 hours dark, at this stage. Treatment commenced seven days later in 
order to reduce maternal influences, the major source of variability in body weight 
and composition at weaning (Eisen, 1974). Consequently treatment started when the 
mice were 4 weeks of age and continued until they were 7 weeks of age, thus 
covering the period of rapid growth. BP expanded diet number one (special diets 
services, Witham, Essex, UK.), and water wete  available ad libitum throughout the 
period from weaning until the end of the experiment. The same food was available as 
mash until all the mice in a cage weighed lOg, at which weight the animals appeared 
to be able to reach the pelleted food and the water bottle (personal observation). 
The recombinant bovine growth hormone (rbOH) used was kindly donated by the 
American Cyanamid Co., New Jersey. It was given as a sterile solution prepared in 
isotonic bicarbonate buffer (pH 9.4) or an isotonic saline placebo. All animals were 
injected within the two hours before the start of the dark period with 
5 p1 fluid/ gram body weight/ day. 
For this preliminary trial three concentrations of OH were used, 1.8mg/mi, 
0.3mg/mi and 0.05mg/mi. These gave daily doses per gram body weight as shown in 
Table 2.1. All mice used were males from the fat F-Line, 11 generations after the 
cross, that is after 31 generations of selection. 
Three lit/lit mice were used to ensure that the recombinant bovine OH (rbGH) 
used was active in mice. They were drawn from lit/lit stock in a C57/BL6J 
background maintained in the same mouse house as the F and P lines, on the same ad 
libitum diet. One received saline at 5p1 /g /day, one 0.25sg OH /g /day and one 9j.tg 
OH /g /day. They were injected in the same way as the F-Line mice. Their weights 
were recorded on a graph on a daily basis. The injections were discontinued after 15 
days as it was clear that the mouse on the high dose of OH was growing faster (See 
Figure 2.1) and hence the preparation used probably had biological activity in the 
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Table 2.1 
Preliminary trial of the effects of Gil on male mice from the fat F-line from 4 to 7 
weeks of age. Treatments given and number of mice in each treatment group. 
Animals were kept in a 141w light, 10 hour dark cycle with food (SDS number 1 
food) and water available ad libitum.. Injections were given daily for 21 days in 
the two hours before the start of the dark period. 
Groun 	 Treatment 
control 	 5 a1 saline/glday 
Low Dose 0.25 jag GHJg/day 
Medium Dose 	1.5 sg GHJg/day 
High Dose 9 jag GHJgIday 
* This group started with 9 mice , but 3 escaped 







Weights were taken daily, immediately before the injection. Mice were weighed 
and then killed by cervical dislocation on the day after the final injection during the 4 
hours before the start of the dark period. The liver, kidney, spleen and gonadal fat pad 
(GFP) were dissected out and weighed. These organs were chosen to monitor 
changes in fat content (GFP), general metabolism (liver and kidney), and to monitor 
immune stress caused by the injection of a foreign protein (spleen). Spleens vary in 
shape and weight within and between lines (Dunn, 1954) so a crude comparison of 
weights was unlikely to give unambiguous information. However dissection and 
visual inspection ensured that they were checked for gross abnormalities which might 
indicate immune stress. 
2.2.1 Method of Analysis 
The means and standard errors of means plotted in Figures 2.1 and 2.2 were 
simply calculated for each treatment group. No allowance for family effects was 
made. The statistical analysis was carried out using a mixed model least squares and 
maximum likelihood computer program (Harvey, 1985). All analyses were carried 
out on natural log transformations of the weights to avoid scale effects that would 
otherwise be present in subsequent analyses of the P-Lines due to the size differences 
between those lines. Scale effects were unlikely to be important in this trial as only 
one line was investigated. 
2.3 Results 
Figure 2.1, which shows the weights of lit/lit mice over an eighteen day period, 
suggests that mice respond to the rbGH used in this trial, at least at the highest dose. 
Only one mouse was tested at each dose, but the animal given 9j.tg GHJ g body 
Figure 2.1 
Weights of individual little mice after treatment with OH or saline. The animals were injected 
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Mean daily gains of male Fat F-Line mice injected daily with saline or recombinant bovine OH 
from 4 to 7 weeks of age. Doses were as given in the key. The error bars shown give the 
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weight per day gained approximately twice as much as the animals given either saline 
or the lowest dose of rbGH. This was however only 3 to 4 g more than the latter 
animals. The little stock is inbred and it is unlikely that inbred mice would show this 
level of variation in growth rate purely by chance. Effects of similar absolute, as 
opposed to proportional magnitude would be less noticeable in normal mice with 
their much higher rate of gain over the period of study. The mean gains over the 
period of the Fat line mice (Figure 2.2), do not show such a clear effect, although it 
appears that the high dose group has gained more over the treatment period than the 
control or lower doses. 
No significant effects of treatment were noted on body weight or gain (Table 2.2). 
However when the three groups which were treated with rbGH were compared there 
appeared to be a trend of increasing gain with increasing dose. This in conjunction 
with the results from Figures 2.1, 2.2 suggested that the rbOH has increased growth. 
Although the sample size used was too small to detect the effect it suggested that 
further experiments should be conducted. There does not appear to have been any 
effect on gonadal fat pad weight as a proportion of body weight. 
The significant effect recorded on kidney weight may be due to the treatment, in 
that kidney weight seemed to decline as a proportion of carcass weight with 
increasing dose. However the significant effects observed for spleen and liver 
weights as a percentage of carcass weight did not appear to follow any trend. This 
suggests that the results may have been a statistical quirk, resulting in part from the 
small sample sizes used (Table 2.2) 
2.4 Discussion 
The results suggest that these mice responded to the recombinant bovine OH 
used. Consequently it would be suitable for investigating differences between the 
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Table 2.2 
Body and organ weights of mice from the fat F-line 
Male mice were injected daily for 21 days from 4 to 7 weeks of age with one of three 
concentrations of rbGH or with saline. Organ weights given are as a percentage of final body 
weight. All traits other than initial weight are regressed onto Ln(initial weight) The data were 
analysed by the analysis of varience and a mixed model least square and maximum likelihood 
computer program. 
Control 	0.25jxg Gill 	1.5g Gill 	94g Gil/ 	Sign 	S.E. 
(Saline) 	g body wt 	g body wt g body wt 	teat 	Means 
	
/day 	/day 	May 
Ln(init wt) 	2.38 	2.33 	2.3 	2.34 	NS 	±0.05 
(initial wt (g(10.8) 	(10.3) 	(10.0) 	(10.4) 
Ln(flnal wt) 3.34 	3.30 	3.32 	3.34 	NS 	±0.029 
(final wt (g)) (28.2) 	(27.1) 	(27.7) 	(28.2) 
RG(overall) 0.99 	0.95 	0.97 	1.00 	NS 	±0.03 
GFP weight 0.70 	0.60 	0.63 	0.63 	NS 	±0.05 
(% body weight) 
Liver weight 2.59 	2.53 	2.28 	2.34 	* 	±0.088 
(% body weight) 
Kidney weight 0.62 	0.59 	0.58 	0.55 	* 	±0.25 
(% body weight) 
Spleen weight 0.12 	0.14 	0.16 	0.14 	 ±0.008 
Ln 	natural logarithm 
RG 	relative gain, calculated as the difference between the natural logs of 
the initial and final weights of the treatment period 
NS 	no significant difference between the groups being compared 
* Pc0.05, ** Pc0.01 for line treatment or interaction effects 
The data were analysed by analysis of variance with a mixed model least squares 
and maximum likelihood computer program (Harvey, 1985). 
M. 
lines in response to exogenous GH. It is likely that the non-significant difference 
between the control and Gil treated groups in this trial is due to the small sample 
sizes used. The data gathered was used to provide parameters to calculate the number 
of mice needed by the following method (Chapter 6, Snedecor and Cochran, 1980) 
Assuming a mean gain of 20g for untreated mice between 4 and seven weeks of 
age from the data 
To identify a difference between the means, S of 2g, (or 10%), with a probability, 
P 1 =0.95, at a significance level 0.99 and a standard error between the means, a of ig, 
(or 5%) using a two tailed test a sample size, n, was needed, where 
n=M x 2 x a2 
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where M is a multiplier related to the significance level and probability of detection 
required. In this case M=17.8 (table 6.14.1, p104, Snedecor and Cochran). 
so 	n=(17.8x2x52)/(10)2 
n=8.9 
Rounding up, and adding two to correct for the approximate formula used gave 
n=11 
that is, 11 mice per treatment group were needed. 
This confirms that the samples used were too small to reliably detect an effect due 
to GH. Further work should be carried out on samples of at least 11 mice per 
treatment group, preferably a few more to allow for such events as illness, escaping, 
and incorrect determination of sex. 
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Chapter 3 
Effects of GH on F and P-Line mice. 
3.1 Introduction 
The data from the preliminary trial indicated that the rbGH used was growth 
promoting in normal mice. This suggested that it would be practical to use the rbOH 
to identify and analyse any differences in the reactions of the lines differing in fat 
composition and those differing in body weight to exogenous OH. The preliminary 
trial had indicated that the highest dose, 9g/g body weight/day, was the only one 
tested to have induced an increase in growth, consequently this dose was used for the 
treatment of the four lines. 
Traits not analysed in the preliminary trial were studied in this experiment. 
Pectoralis muscle weight was recorded as the pectoralis is an easily dissected muscle, 
and tibia length as it is a large identifiable bone. These provide information about 
changes in muscle mass and skeletal growth respectively. Measuring a small bone 
would have limited utility as the measurement error would have been a greater 
fraction of the bone length, and possibly have masked differences due to the OH. 
These measurements would hopefully give further information on any differences 
between the line in the partitioning effects of OH. The carcasses were also freeze 
dried to obtain another estimate of percentage fat in the body as initial selection was 
based on gonadal fat pad weight so the drying method gave a non-biased estimate of 
overall body composition (Hastings and Hill, 1989). 
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3.2 Materials and methods 
3.2.1 Animals 
The mice used in this experiment were taken from the line which resulted from 
the crossing of the original three replicates. The F-Line came from generation 12, 
and the P-Line generation 13, after the cross. That is after a total of 32 or 33 
generations of selection respectively (section 1.6). The F and P lines were 
non-contemporaneous. They were housed from weaning in controlled light 
conditions (14h light, lOh dark) and fed the same ad libitum diet as the animals in the 
preliminary trial. Only males were used to avoid the confounding effects of sex 
based differences. 
Mice were assigned randomly within family to the control or treatment group 
when weaned at 21 (±2) days. Treatment commenced 7 days later in order to reduce 
maternal influences, the major source of variability in weight at weaning (Eisen, 
1974). Animals were treated with recombinant bovine growth hormone at 9jsglg 
body weight/day, given as a 1.8mg/nil sterile solution prepared in isotonic 
bicarbonate buffer (pH 9.4) or with a saline placebo at (O.lml/20g body weight) daily 
from 4 to 7 weeks of age. Injections were given subcutaneously within the 2 hours 
before the start of the dark period and the mice were weighed immediately before 
injection. 
• On the 21st day after the treatment started the mice were weighed and then killed 
by cervical dislocation. The Jiver, spleen, kidneys, gonadal fat pad (GFP) and 
pectoralis muscle were dissected out and weighed. The organs were then restored to 
the carcass which was freeze dried and weighed. Finally the hind legs were taken and 
boiled to remove the flesh, enabling tibia length to be measured. The length did not 
include the terminal epiphyses. 
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Three lit/lit mice were used to confirm that the rbGH had not lost its biological 
activity. Two were treated with rbGH, and one with saline. The dose and regimen of 
administration were as described for the F and P-Line mice. Weights were recorded, 
but the animals were not dissected at the end of the treatment period. 
3.2.2 Statistical Analysis 
The results were analysed using a mixed model least squares and maximum 
likelihood computer program (Harvey, 1985). Analyses were carried out using a 
model with family as random effect, nested within line, with line and treatment as 
fixed, crossclassified effects. The model also tested for line by treatment interactions. 
All analyses used natural log transforms of weight to remove scaling effects due to 
the substantial difference in size between the high and low selected P-line mice. 
Traits, other than initial weight, were also regressed on the natural log of initial 
weight to remove the effects of initial body weight differences between animals. This 
regression reduced the standard errors of the means in the analyses. (Log final weight 
showed a correlation with initial weight of over 0,80 for all lines other that one 
selected for high body fat, in which the correlation exceeded 0.65). Relative gain was 
also analysed as its -logarithm, calculated for each animal as 
(natural log final weight) -(natural log initial weight). 
3.3 Results 
All the lines of mice in this study responded to rbGH by increasing their growth 
rate (Tables 3.1 and 3.2). At 4 weeks of age, before treatment, there was no 
significant difference in body weight between the lines selected for high and low fat 
percentage (F-Lines) (Table 3.1). The line selected for high body weight was 
significantly (pc0.01) heavier, by about 9g, at the start of treatment than the line 
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Table 3.1 
Body weights of mice selected for high and low body fat content (F-Lines). Male mice from the fat and lean 
lines were injected daily from 4 to 7 weeks.of age with 9jsg rbGH/g body weight/day, or with 0.1 ml 
saline/20g body weight/day. All traits other than initial weight were regressed on Ln(initial weight) 
Fat 	Lean 	Significance Significance Significance S.E. 
Treatment 	Line 	Interaction Mean 
Saline OH Saline OH 
Number of 18 17 18 18 
animals 
Ln Body Weight 2.94 2.89 2.93 2.84 	* NS 	* 	±0.084 
at 4 weeks 
(initial body wt (g)) (18.9) (18.0) (18.5) (16.9) ±L1 .09 
LuBody Weight 3.39 3.47 3.32 3.40 	** ** 	NS 	±0.017 
at 7 weeks 
(Final body wt (g)) (29.7) (32.0) (27.0) (30.2) ±(1.02) 
RG(overall) 0.49 0.57 0.42 0.51 	** ** 	NS 	±0.017 
Ln 	natural logarithm 
RO 	relative gain, calculated as the difference between the natural logs of 
the initial and final weights of the treatment period 
NS 	no significant difference between the groups being compared 
* Pc0.05, ** Pc0.01 for line treatment or interaction effects 
The data were analysed by analysis of variance with a mixed model least squares 
and maximum likelihood computer program (Harvey, 1985). 
33 
Body weights of mice selected for high and low whole body weight (P-Lines). Male mice were injected daily 
from 4 to 7 weeks of age with 9sg rbGH/g body weight/day, or with 0.1 ml saline/20g body weight/thy. All 
traits other than initial weight were regressed on Ln(initial weight) 
High 	Low 	Significance Significance Significance S.E. 
Treatment 	Line 	Interaction Mean 
Saline 	GH 	Saline 	GIl 
Number of 	30 	30 	30 	30 
animals 
Ln Body Weight 3.13 3.13 2.68 2.53 	* ** 	** 	±0.067 
at 4 weeks 
(initial body wt (g)) (22.9) (22.9) (14.6) (12.6) ±(1.07) 
Ln Body Weight 3.63 3.71 3.16 3.23 	** 
** 	NS 	±0.021 
at 7 weeks 
(Final body wt (g)) (38.1) (40.0) (23.6) (25.3) ±(1.02) 
RG(overall) 0.83 0.90 0.33 0.40 	** ** 	NS 	±0.049 
Ln 	natural logarithm 
RG 	relative gain, calculated as the difference between the natural logs of 
the initial and final weights of the treatment period 
NS 	no significant difference between the groups being compared 
* Pc0.05, ** Pc0.01 for line treatment or interaction effects 
The data were analysed by analysis of variance with a mixed model least squares 
and maximum likelihood computer program (Harvey. 1985). 
34 
Fieure 3.1 
Mean daily gains of mice selected for high and low body fat content (F-Lines). Male mice from the 
lines were injected daily from 4 to 7 weeks of age (groups as in the key). Error bars show the 
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Mean daily gains of mice selected for high and low body mass (P-Lines). Male mice from both 
lines were injected daily from 4 to 7 weeks of age (For groups see key) Error bars show the 
maximum standard error for each line and treatment group 
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selected for low body weight and gained twice as much weight over the test period 
(Table 3.2). In both body weight lines the gain of the treated mice was a factor of 
1.15 greater than that of the untreated mice (Figure 3.2). Mice selected for high and 
low fat percentage grew at similar rates throughout the treatment period (Figure 3.1) 
and both lines responded with an increase in weight gain of 3 to 4 g when treated with 
rbGH. This is a factor of approximately 1. 1, similar to the 1.15 noted for the P-Lines 
and to that noted in chapter 6. Cumulative gains were plotted rather than weights as 
the mice assigned to be injected with rbCIH were significantly lighter than mice 
assigned to the group to be given saline in the line selected for low body weight and 
the line selected for low body fat percentage, by chance (Tables 3.1 and 3.2). 
From figures 3.1 and 3.2 it appears that the rbGH has caused the maximal rate of 
weight gain to be maintained for a longer period than in untreated mice, resulting in 
greater weight gain over the whole period and greater final weights. The rbOH also 
appeared to induce growth in the OH deficient little mice (Figure 3.3). 
There is an apparent discrepancy between the values of the relative gain in the 
tables, and that which can be calculated from the initial and final weights given. The 
initial weight given has not been regressed onto itself, while final weight has been 
regressed onto initial weight. The relative weights have also been regressed onto 
initial weight. The method of calculating the relative gain involves the initial weight 
as well as final weight, so there will be different correction factor applied to relative 
gain, than to final weight, because of their regression on initial weight. The 
discrepancy is greater in the body weight lines due to the greater difference in weight 
between these lines (Tables 3.1 and 3.2). 
Gonadal fat pad and dry matter percentages are indicators of the amount of fat in 
the carcass as expected. Both were significantly (p<0.0 1) greater in the high fat line 
than in the low fat line (Table 3.3). Gonadal fat pads were proportionately smaller in 
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Table 3.3 
Organ weights of mice selected for high and low body fat content (F-Lines). Male mice from the fat and lean 
lines were injected daily from 4 to 7 weeks of age with 9sg rbGHJg body weight/day, or with 0.1 ml 
saline/20g body weight/day. Organ weights are as a percentage of final body weight. All traits were regressed 
on Ln(initial weight) 
Fat 	Lean 	Significance Significance Significance S.E. 
Treatment 	Line 	Interaction Mean 








Gonadal Fat Pad 	1.09 	1.06 	0.41 	0.36 MS 	** 
(% body weight) 
Dry body weight 	38.6 	37.9 	31.8 	29.9 	* 	** 
(% Wet body weight) 
Pectoralis muscle 	0.35 	0.29 	0.30 	0.38 NS 	MS 
(% body weight) 
Tibia bone 	16.5 	16.6 	16.6 	16.8 	NS 	MS 
length (mm) 
Liver weight 	5.5 	5.5 	5.4 	5.2 	NS 	MS 
(% body weight) 
Kidney weight 	1.43 	1.37 	1.58 	1.53 	* 	** 
(% body weight) 
Spleen weight 	0.31 	0.32 	0.40 	0.41 NS 	* 
(% body weight) 
Ln 	natural logarithm 
RG relative gain, calculated as the difference between the natural logs of 
the initial and final weights of the treatment period 
NS 	no significant difference between the groups being compared 
* Pc005 ** Pc0.01 for line treatment or interaction effects 
The data were analysed by analysis of variance with a mixed model least squares 
and maximum likelihood computer program (Harvey, 1985). 
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Table 3.4 
Organ weights of mice selected for high and low whole body weight (P-Lines). Male mice were injected daily 
from 4 to 7 weeks of age with 9jsg rbGH/g body weight/day, or with 0.1 ml saline/20g body weight/day. 
Organ weights are as a percentage of final body weight. All traits were regressed on Ln(initial weight) 
High 	Low 	Significance Significance Significance S.E. 
Treatment 	Line 	Interaction Mean 
Saline GH Saline CR 
Gonadal Fat Pad 0.47 0.50 0.95 0.56 NS 
** NS ±0.088 
(% body weight) 
Dry body weight 33.1 36.0 36.0 35.2 NS NS NS ±1.63 
(% Wetbody weight) 
Pectoralis muscle 0.36 0.35 0.34 0.34 NS NS NS 0.028 
(% body weight) 
Tibia bone 17.2 17.6 15.8 16.0 MS ** MS ±0.23 
length (mm) 
Liver weight 5.8 5.5 5.4 5.3 NS MS MS ±0.17 
(% body weight) 
Kidney weight 1.47 1.38 1.55 1.49 * NS MS ±0.069 
(% body weight) 
Spleen weight 0.38 0.44 0.22 0.21 NS ** * ±0.023 
(% body weight) 
Ln 	natural logarithm 
RU relative gain, calculated as the difference between the natural logs of 
the initial and final weights of the treatment period 
NS 	no significant difference between the groups being compared 
* Pc0.05, ** Pcz0.01 for line treatment or interaction effects 
The data were analysed by analysis of variance with a mixed model least squares 
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the high P-line mice (pcO.Ol) (Table 3.4). This may be due to the original selection 
criterion being fat free mass, predicted from gonadal fat pad weight and body weight. 
Treatment with rbGH had no significant effect on gonadal fat pad weight as a 
percentage of body weight in the P or F-Lines or on dry weight as a percentage of 
body weight in the P-Line. An effect of treatment on dry body weight in the F-Lines 
was observed (Tables 3.3 and 3.4). Also when all four lines were analysed together 
there was a significant (p'c0.05) line by treatment interaction for dry weight 
percentage. These may be chance effects or indicate between line differences in the 
involvement of OH in fat regulation. 
The pectoralis was chosen as a representative, easily dissected muscle which 
could be used to estimate the effects of OH on muscle mass. OH treatment did not 
affect pectoralis weight as a percentage of final weight in the lines selected for body 
weight (Table 3.4). GH treatment reduced pectoralis weight as a percentage of final 
weight in the high fat mice but increased it in the low fat mice (Table 3.3). This was 
apparent as significant line by treatment interactions (p'cO.OS), and suggests that 
selection in the high fat mice has altered the interaction of OH with metabolism. 
The high body weight line had a significantly (pcO.Ol) greater tibia length than 
the low body weight line (Table 3.4). Tibia length was consistently, but not 
significantly, greater in treated animals than in the control group in each of the lines 
of mice (Tables 3.3 and 3.4). 
There were no significant line or treatment effects on liver weight as a percentage 
of body weight. The significant (pc0.05) reduction in kidney weight as a percentage 
of body weight (Tables 3.3 and 3.4) after treatment implies that the kidney is less 
susceptible to OH than other tissues. This may be due to kidneys reaching their final 
size before the rest of the body, or reflect distribution of OH receptors. A significant 
(pc0.05) difference between lines in spleen weight as a percentage of body weight 
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was noted in these experiments, as was a significant (pc0.05) interaction between line 
and treatment in the body weight lines (Tables 3.3, 3.4). Previous studies have shown 
that spleen size and shape vary considerably between inbred strains (Dunn, 1954). 
This suggests that the differences may be due to drift following the long separation of 
the lines. No pathological changes were noted. 
3.4 Discussion 
OH treatment increased the rate of weight gain and final weight in mice of all 
lines. The similarity of the response between lines in terms of the increase of weight 
gain and final weight relative to initial weight suggest that selection has not altered 
the ability to respond to OH. The effect of selection on response to GH might have 
been expected to be greatest in the lines selected for high and low body weight. 
Studies in other lines of mice selected for high and low body size indicated that the 
mice selected for smaller size were also less responsive to OH (Pidduck & Falconer, 
1978). Other research has shown that OH concentration often does not show obvious 
correlations with differences in rates of weight gain and body size. Broiler chickens 
have lower levels of plasma OH than slower growing layer lines (Burke & Marks, 
1982, Stewart & Washburn, 1983). 
The general increase in tibia bone length in mice treated with rbOH indicates a 
long lasting effect of the OH on growth, as it increased bone growth. Some of the 
greater body weight observed in treated animals may be accounted for by their 
increased bone size and bone weight. In sheep a substantial increase in non-carcass 
components of the body, such as skin, fleece and gut was observed after OH 
treatment (Johnsson ci' al, 1987). Skin and gut may account for part of the greater 
weight observed in these treated mice. 
Treatment with rbOH did not significantly affect fat content as measured by 
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gonadal fat pad percentage and dry weight percentage although there was generally a 
slight decrease. The results in this study may be due to species specificity with rbGH 
having a lesser effect on fat deposition in mice than it does in lambs (as human OH 
had no significant effect in pigs (Baile et al, 1983)). It might have been expected that 
the fat mice, having the greatest fat percentage, and hence potential for reduction, 
would have shown the greatest reduction in body fat after treatment with rbOH but 
this was not the case. This may be due to selection having altered the way OH affects 
growth and maintenance of fat deposits in the fat line. 
The principal conclusion from these experiments is that mice from all the lines 
studied respond to treatment with rbOH by gaining weight fractionally, i.e. around 10 
to 15 percent, faster. This growth is not solely due to an increased rate of gain of 
protein and is probably also due to greater growth of the bones, gut and skin. As the 
lines all reacted very similarly in terms of increase of final weight relative to initial 
weight, and of gain relative to initial weight it can be concluded that there is no 
difference between them in theft response to exogenous OH. The mice also showed 
some evidence of a reduction in fat after treatment, which supports previous work 
showing that exogenous OH improves carcass quality by reducing fat percentage. It 
appears therefore that the differences in growth rate observed in these lines are 
possibly not due to differences in responsiveness to OH. Any involvement of OH in 
these genetic differences may lie in differences in synthesis or secretion. 
The major effects were observed in the P-Lines. This suggests that further 
investigations could most profitably be carried out in the P-Lines. Possible lines of 
investigation include assaying OH levels in both the high and the low line, and an 
investigation of the effect of removing OH. It is possible that plasma levels of OH 
regulate the number of receptors available, in which case an increase in plasma OH 
levels would result in an increase in receptor levels. Thus the proportion of receptors 
available to respond to endogenous OH would be similar, regardless of plasma levels 
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of OH. If that is the case, removing OH could cause disproportionate effects. 
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Chapter 4 
GH Assay and investigation of preweaning growth 
4.1 Introduction 
The high and low P-Lines do not differ in their response to injection of rbGH. 
This implies that either both the levels of endogenous OH and of its receptors have 
changed to the same extent, possibly due to OH regulation of receptor levels, or that 
the size difference between the lines is not due to differences in OH or its receptors. 
One way to distinguish these possibilities would be to assay GM in both lines at 
several ages. OH is produced in the pituitary and released into the blood for 
transport, thus OH concentrations in the blood or the pituitary could be assayed. 
Blood is easier to obtain, but GH levels in serum are cyclical in rats (Robinson and 
Clark, 1987) and humans (Phillips, 1987) and can vary considerably, e.g. by a factor 
of at least 10 in the female rat (Robinson and Clark, 1987). Similar variability may 
well occur in the mouse. This suggests that between line comparisons of single 
samples of serum would yield little useful information. Repeated samples would 
need to be taken over a period, then the resultant secretory patterns' could be 
compared. However mice are too small to readily permit repeat sampling. It is 
possible that OH levels in the pituitary are more stable and analysis of these could 
give more information about differences between the lines. A large number of blood 
samples might identify substantial differences in OH levels between the lines. 
The collection of pituitaries involves removing the head, so animals were killed 
by decapitation, which enabled collection of a terminal blood sample. Four age 
groups were sampled, 4 and 7 weeks of age, that is, the beginning and end of the age 
range for treatment with rbGH, and 5 and 10 weeks old, as other analyses have been 
carried out on these lines at those ages (Sharp et al, 1984, McKnight and Goddard, 
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1989). Indeed selection was based on measurements made on ten week old mice 
(Sharp a al, 1984, Bootland et al, 1991). Only males were investigated, as in the 
previous experiments with rbGH, to avoid the complications of sex linked 
differences. 
Although mice generate GH from day 16 of foetal life (Slabaugh a al, 1982) GH 
does not seem to be necessary for body weight gain until 14 days after birth (Borrelli 
a al, 1989). Investigation of growth rate of the P-Lines from birth to weaning might 
identify differences in growth rate, which would imply GH was not involved in those 
differences. The average litter size at birth in the high P-Line is approximately twice 
that in the low line (Brien a al, 1984), that is in proportion to maternal weight. Any 
differences in birth weight suggests there may be in utero differences in gowth rate 
due to individual effects, not maternal effects. It would be simple to weigh the litters 
which are being produced to provide mice for the GH assay but identifying individual 
pre-weaning mice is difficult, especially before the growth of fur. The methods 
available, such as toe clipping, involve injuring the animals and are not suitable in 
this case as the mice are to be used for further investigation later and toe clipping. 
However weighing a whole litter at once was possible, and was used to calculate the 
average weight of mouse as litter size was recorded. 
There may also be a limiting effect on growth due to limits on the dam's supply 
of milk. In mice selected on body weight artificial adjustments in litter size found 
litter size was inversely correlated to weaning weight of pups (Hayes and Eisen, 
1979). Any limitations of maternal milk production on preweaning growth in the low 
line should be relieved by fostering onto high line dams, which normally nurse larger 
litters. The crossfostering would not be expected to yield useful information about 
maternal effects on preweaning growth of high line mice as there are too many effects 
being altered. 
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4.2 Preweaning growth 
4.2.1 Materials and Methods 
4.2.1.1 Animals 
The mice used were the offspring of matings of surplus P-Line stock. Preweaning 
weights were recorded on whole litters, including both males and females for the first 
and second litters. All second litters studied were carried while the dam was nursing 
the first litter. Third litters were produced from the same pairs and used in the 
crossfostering. For the first two litters, litters with more than 12 pups were culled to 
12 at birth. 
For crossfostering litters were standardised to 8 pups, the average for the low line. 
There were not enough litters born on any one day to cross foster litters born on the 
same day. Every other day the litters were taken. Eight pups were selected randomly 
from the low line, and rolled in sawdust from the sleeping area of a dam from the 
high line. She was then given the pups to foster. The rolling in sawdust was to add 
the scent of the foster mother's pups to the pups' own scent and hopefully improve 
the chances of successful fostering. This continued until all high line dams had a 
litter. The procedure was then repeated with high line pups and low line dams. Any 
high line pups remaining were killed. 
All the mice in each litter were weighed together every morning, from birth (or 
fostering) to weaning at twenty one days of age. Any deaths that had occurred since 
the previous day were recorded. At weaning the mice were separated from the dam, 
identified by ear clips and moved into single sex cages. Mice from the second litters, 
and the crossfostered litters were then weighed daily until they reached 28 days of 
age. 
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4.2.1.2 Statistical Analysis 
Mean mouse weight at birth for each litter was plotted against number of mice in 
that litter for each line separately and then birth weight was regressed onto litter size. 
The weight of each pre-weaning litter was divided by the number of nice in the 
litter to find the average weight. Means and standard errors of these were calculated 
and plotted. Mean mouse weight was used rather than mean litter weight, because of 
the differences in litter size. The high line dams have a mean litter size of more than 
twice that of the low line dams, before culling to a maximum of 12 (Brien a al, 1984) 
for the figures. Means and standard errors were calculated using individual mouse 
lrc 0r L-reoL,cnE 
weights after weaning. No allowance forAeffects  was made when calculating the 
means and standard errors. 
Statistical analysis was performed on the preweaning weights using a mixed 
model least squares and maximum likelihood computer program (Harvey 1985), 
using a model with dam as random effect, nested within line, and line and litter status 
(first, second or crossfostered), as fixed, crossclassified effects. Line by treatment 
interactions were also tested for. Analyses of initial and final weights were carried 
out on theft natural log transformations to remove scaling effects due to the 
substantial difference in size between the lines. Traits, other than initial weight, were 
also regressed on the natural log of initial weight. Relative gain was analysed as its 
logarithm, calculated for each animal as (natural log final weight) -(natural log initial 
weight) for the period in question (As in chapters 2 and 3) 
4.2.2 Results 
The results were obtained from ten families per line for the first litter and the 
second low line litter in the low line. Due to parental deaths, the results for the 
second high line litter and for the litters which were crossfostered were obtained from 
eight families per line. 
The regression of mean mouse weight at birth on litter 6 je at birth was not 
significantly different from zero for either line. From Figures 4.1 and 4.2 it appears 
that most of the litters born fell within a limited range for litter size of 6 to 8 pups in 
the low line, 14 to 18 pups in the high line. 
From Table 4.1 it appears that high line mice are approximately 1.4 times as 
heavy as low line mice at birth and there is a difference of almost a factor of two 
between the lines in litter size. High line mice are significantly heavier than low line 
mice at birth. At weaning there is no significant difference in weight between the 
lines, although the high line is still heavier (Table 4.1). Nor do the high and low line 
differ significantly in relative gain during preweaning growth (Table 4.1). This is 
also reflected in Figure 4.3 with the lines gaining at similar rates until three or four 
days before weaning. The increased rate of gain of body weight observed could be 
temporary, to investigate this the weights of the second litters and crossfostered litters 
were recorded for a week after weaning, until they reached four weeks of age. The 
increased rate of gain was observable throughout the extra week analysed (Figures 
4.4,4.5). 
There is an apparent discrepancy between the values of the relative gain in Tables 
4.1, and that which can be calculated from the initial and final weights given. The 
initial weight given has not been regressed onto itself, while final weight has been 
regressed onto initial weight. The relative weights have also been regressed onto 
initial weight. The method of calculating the relative gain involves the initial weight 
as well as final weight, so there will be different correction factor applied to relative 
gain, than to final weight, because of their regression on initial weight. This is 
similar to effects noted in chapter 3. 
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Figure 4.1 
Plot of mean weight at birth of mice in a litter against the number of 
mice in a litter for the high P-Line. The regression of birth weight on 














Plot of mean weight at birth of mice in a litter against the number of mice in 
a litter for the low P-Line. The regression of birth weight on litter size was 






















Preweaning weights and gains of P-Line mice 
High line Low Line Significance Significance S.E. 
liner liner cross litter liner cross I line liner means 
1 2 foster 1 2 foster effects effects 
(mean litter size) (11.1) (12.0) (7.7) (6.5) (7.7) (8.0) 
Ln(initialwt) 0.609 0.709 0.711 0.236 0.342 0.391 ** ** ±0.044 
(mit wt (g)) (1.84) (2.03) (2.04) (1.27) (1.41) (1.48) 
Ln(3 Week wt) 2.331 2.075 2.407 2.108 2.047 2.345 MS ** ±0.094 
(3 Week wt(g)) (10.29) (7.96) (11.10) (8,23) (7.74) (10.45) 
RG(week 1) 1.067 1.039 0.995 0.915 0.911 1.124 MS NS ±0.064 
RG(week 2) 0.488 0.324 0.533 0.385 0.349 0.423 MS ** ±0.052 
RG(week 3) 0.292 0.231 0.395 0.325 0.303 0.316 NS MS ±0.025 
RG(Preweaning) 1.847 1.591 1.923 1.624 1.563 1.863 MS ** ±0.094 
Ln, Natural Logarithm 
RG, Relative gain, calculated as the difference between the natural logs 
of the initial and final weights of the period in question 
NS, no significant difference between the groups being compared. 
* N0.05, ** P<0.01) 
Figure 4.3 
First litter. Mean daily weights of mice from birth to weaning. The mean 
weight of mice in a litter was found by dividing litter weight by the number of 
mice in a titter. Then the mean of those means was calculated and plotted. The 



















Second liner. Mean daily weights of mice from birth to 28 days. The mean 
weight of mice in a litter was found by dividing litter weight by the number of 
mice in a liner. Then the mean of those means was calculated and plotted. The 
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Crossfostered liner. Mean daily weights of mice from birth to 28 days. The 
mean weight of mice in a litter was found by dividing liner weight by the number 
of mice in a litter. Then the mean of those means was calculated and plotted. The 
error bars give the maximum standard error of the final mean. The line specified in 
the key is the genotype of the pups, not their foster mother. 
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There is a significant litter effect on three week weight, and on relative gain for 
the whole preweaning period. The second litter of both lines have a lower three week 
weight than the first litters or crossfostered litters, and a lower relative gain for every 
period except the first week (Table 4.1). Temperatures in the animal house were over 
32°C during this period and the reduced growth may reflect the effects of heat stress 
on the pups or dams. Thus second litters should not be used as control to detect any 
effects of fostering low-line pups onto high line dams and vice versa. Low line pups 
fostered onto high line dams approximately 26% more at three weeks of 
age (weaning), and have a relative gain for the the whole preweaning period 
approximately 15% greater, than low line pups from the first low line litter (which 
were nursed by low line dams) (Table 4.1). High line pups suckled by low line dams 
have a final weight approximately 8% greater, and an overall preweaning relative 
gain approximately 4% greater than that of the the first high line litter, which were 
nursed by high line dams. This suggests that low line pups grow faster when suckled 
by high line dams than low line dams. As the low line mice still increased the rate of 
weight gain at 18 days (Figure 4.3) food supply cannot be the only factor responsible 
for this increase in weight gain. 
The difference in rate of gain between the lines continues until at least ten weeks 
of age (Figure 4.6). Low line mice weigh less at all these ages, and the rate of gain of 
weight of low line mice appears to show a greater reduction between 5 and seven 
weeks of age than that of the high line, 
4.2.3 Discussion 
The regression of birth weight on litter size at birth was not significantly different 
from zero for both lines which suggests that within a line factors other than litter size 
have more effect on birth weight than litter size (Figures 4.1, 4.2). 
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Mean weights of male P-line mice from 4 to 10 weeks of age. Error bars 

















Only tentative conclusions can be drawn from these experiments as the second 
litter was in utero while the first was being suckled. The increased demands on 
maternal metabolism of simultaneous milk production and pregnancy maintenance 
may have reduced growth in the first or second litters, or in both. Also there were 
problems with regulating the temperature in the mouse house during the preweaning 
period of the second litter. This litter had a lower • rccLe, of gain during this period 
than the first litter, possibly due to maternal heat stress. 
There was no significant difference between the lines in body weight at 3 weeks 
of age, or in relative gain at any point analysed, that is during the preweaning period. 
Given the significant difference between the P-Lines in four week weight noted in the 
previous chapter (Table 3.1) this is unexpected. The lines appear to start to diverge in 
body weight, at around 18 days of age, (Figures 4.3, 4.4, 4.5). The increased rate of 
gain of weight observed in both lines at this point is maintained after weaning. It is 
greater in the high line than the low line (Figures 4.4 and 4.5). OH appears to begin 
to affect the rate of gain at about 14 days of age in the mouse (Borrelli et al, 1989), 
and could be responsible for the observed increase in the rate of gain. However high 
line GH deficient little mice also show this growth spurt (Figures 5.6, 5.7) suggesting 
that OH is not primarily responsible for the increase in the rate of weight gain, 
although it is involved, wild type mice had a greater increase than little mice. 
Mice appear to start to feed themselves at around 18 days of age, in that litters 
whose dam dies after that age are likely to survive, whereas before then they will die 
unless they can be fostered (Personal observation). It is possible that mice are limited 
in their growth by the food supply before weaning, and that growth increases once 
they are no longer dependent on milk from the dam. The crossfostering should check 
this, if food supply is limiting growth, low line mice being suckled by a high line dam 
should have a greater weight at the later preweaning ages than those suckled by a low 
line dam. This does appear to have happened, if the low line mice fostered by high 
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line dams are compared to the first litter of low line pups, which were suckled by low 
line dams (Table 4.1). Hence food restrictions appear to have some limiting effect on 
growth, at least in the low line. Differences between the corresponding litters in the 
high line are smaller (Table 4.1). As the size of litters of high line pups was reduced 
in the cross fostering experiment as well as the pups being nursed by a low line darn 
instead of a high line dam it is not practicable to isolate the effects of cross fostering. 
Hayes and Eisen (1979) altered litter sizes in lines of mice selected on body weight 
by culling and by within line fostering. They found that weight at weaning was 
inversely correlated with litter size. Similar manipulations of litter size in the P-Lines 
should identify effects of food supply on preweaning weight gain in the high line. 
From Table 4.1 it appears that high line mice are approximately 1.4 times as 
heavy as low line mice at birth. The average litter size in the high line is 
approximately twice that in the low line (Brien et al, 1984). Thus the average total 
litter weight at birth in the high line is approximately three times that of the low line. 
Adult mice differ in body weight by a factor of approximately two (Sharp et al, 
1984). This suggests that the difference in litter weights at birth may not be 
explained entirely by factors correlated to maternal body weight and that the pups 
differ in feotal growth rate. This could only be tested by embryo transfer to put 
embryos of different genotypes in the same maternal environment. 
4.3 Assaying Plasma Gil levels 
4.3.1 Materials and Methods 
4.3.1.1 Animals 
The mice used for the assays were the males from the first and second litters 
described in the growth measurements above. Mice from the first litter were assigned 
59 
randomly within family to be killed at either 5 or 10 weeks of age. Similarly, mice 
from the second litter were assigned randomly within family to be killed at either 4 or 
7 weeks of age. This particular division was chosen for reasons of time and space. 
Unfortunately the mice killed at 5 weeks of age were not weighed prior to death due 
to an oversight. Theft litter mates were weighed before being killed at 10 weeks of 
age. The males from the second litter were all weighed at 4 weeks of age and then 
the survivors were weighed at 5 and 7 weeks old. 
4.3.1.2 Collection of samples 
The mice were weighed and then killed, on the day they reached the relevant age, 
with a pair of dog tail clipping scissors, by decapitation. The blood from the head 
and body was passed through a funnel to a eppendorf on ice. The funnel had been 
dipped into a solution of heparin and excess solution drained off before use. The 
heparin solution was 100 I. U. /ml in 0.9% saline, using grade 1 heparin sodium salt 
extracted from porcine intestinal mucosa, obtained from Sigma. The head was then 
cut open using suitable dissecting scissors along a line passing just below the ears to 
the eyes. The upper half of the skull was then lifted with a pair of blunt forceps. This 
generally also lifted the brain. Otherwise the brain was then carefully lifted using 
blunt forceps. The pituitary could then be removed from its location in a small 
depression in the base of the skull and 'placed on ice. The pituitaries from all the 
males of one family were placed in the same container. Once all the males from one 
family had been dissected the pituitaries were dropped into liquid nitrogen. The blood 
was then spun down and the plasma transferred to fresh eppendorfs before both 
plasma and pituitaries were stored in a -60 freezer. Plasma from full sib litter mates 
was pooled for low line mice at 4 and 5 weeks of age due to the small body weight, 
and hence blood volume, of these mice. Due to limitations in time and equipment 
only the plasma samples were assayed. 
Ta 
4.3.1.3 Growth Hormone Assay 
The assay was carried out at the A.F.R.C, Institute of animal production and 
genetic research, Roslin by Dr C. Goddard. 
The Radioactive GH used as label was prepared at Roslin, by the method shown 
(Mouse GH Iodination, Table 4.2) After iodination the immunologically active 
radioactive OH was purified by being run through a PD 10 fractionation column. The 
fractions taken to be purified in the next column are shown in Figure 4.7 . These 
fractions were run through a 0100 column, and those fractions from this column 
which made up the third peak (Figure 4.8) were taken for the assay as peaks one and 
two represent trimeric and dimeric OH respectively. 
The Immunoassay is as shown in Table 4.3 , Mouse OH immunoassay. The 
principal of the assay was to take a known volume of the sample, dilute it with assay 
buffer to a constant volume and mix with antiserum to OH. After incubation 
radioactive iodinated standard OH was added, and incubated. This bound to 
immunoglobulins which had not yet reacted with OH. A second antibody, this time 
to the anti-OH, was added to cross link the antiserum-OH complexes. This caused 
them to precipitate out and the resultant suspension could then be centrifuged, to give 
a pellet of antibody-antiserum-OH complexes and leave the unbound OH in the 
supernatant. The number of molecules of radioactive OH bound was inversely 
proportional to the concentration of OH in the sample. As only bound OH was 
precipitated out the amount of radioactive OH, and hence counts per minute, in the 
pellet at the end of the procedure was inversely proportional to OH concentration in 
the sample. A standard curve was generated using samples of known concentration, 
and used to calculate the OH concentrations in the unknown samples. 
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Mouse OH Jodination 
85p.lPO4 Buffer (300 mm) /I 
101.11 NaT 125 	 (Amersham) 
- 1todObead — P3Waiihë±) 
Incubate for 5 seconds at room temperature 
Add 5jsg (10 s1) m0Hdissolved in a further 2Oiil PO4 
Incubate for 10 minutes at room temperature 
Pet 
Add 400p.1PBSIF2O/azide T2  oi% 	N0 a;cL 3.022 
Run on a PD 10 column and collect 30 fractions 
run the peak through a 0100 column 
store at -20°C in aliquots containing 1.55 x 106 cpm / 500p1 
Columns from NIADDK, NIH, Bethesda, Maryland, USA. 




Counts per minute found in each fraction of the first purification stage in the 
preparation of radioactive iodinated OH. The solution is eluted through a PDIO gel 
filtration column. The first peak is the peak containing iodinated OH, the second is 
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Figure 4.8 
Counts per minute found in each fraction of the second purification stage in the 
preparation of radioactive iodinated OH. The solution is eluted through a 0100 
gel filtration column. The first peak contains OH trimers, the second OH dixners, 
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Table 4.3 
Mouse GH Tmmunoassav 
Dayl 
Assay Buffer 	PBS tablets 	 10 
2% Na azide 10 nil 
Tween 20 	 lml 
Dissolve these in 985m1 distilled water. store at 4 C 
Assay tubes Total Counts (TC) 
Non Specific Binding (NSB) 





These are usually in duplicate or triplicate. 
Antiserum 
Monkey anti-rat GH serum (NIADDK-rGH-S-5) (From NIADDK, NIH, 
Bethseda, Maryland). This is stored in lOOj.tl aliquots (in assay buffer) in the - 
800C freezer. Each Aliquot is a 1:500 dilution of the original serum. 
Make up 1 aliquot to 3.2m1,( 6.4ml or 12.8 ml) with assay buffer to give an 
initial dilution of 1:16 000 (1:32 000 or 1:64 000) (of the original) 
Add 100 p1 of the dilute antiserum to all tubes except TC and NSB 
add 200 p1 of assay buffer to the NSB tubes 
Quality Controls 
High and low quality controls are stored in the -80 0C freezer. 
Standards 
The stock solution is stored in the -800C freezer. This was made from an aliquot 
of 5p.g/10pl by making up to 2.5m1. The sloution is 2p.g/ml and is stored in 25 
aliquots each containing 200ng/100pl. Prepare solutions for the standard curve as 
follows. 
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Table 4.3 cont 
Take 1 aliquot of 200ng/100sl and add 0.9m1 assay buffer. 
This is solution A at a concentration of 200ng/nil 
Take lOOp.xl of solution A and Add 0.9m1 assay buffer. 
This is solution B at a concentration of 20ngIml 
Prepare all the standards according to the following table 




































Put lOOp.! of each dilution into each of two standard assay tubes to give 
duplicates of the final concentration as above. 
Samples 
Samples should ideally be mouse serum, plasma, or clarified pituitary 
homogenate. 
Add 100 p.1 of sample/buffer mixture to the appropriate tubes. 
The assay should now be as follows:- 
Antibody Assay Buffer Sample Standard 
TC 0 0 0 0 
NSB 0 200 0 0 
B0 100 100 0 0 
STDS 100 .0 0 100 
QCH 100 0 100 0 
QCL 100 0 100 0 
SPLS 100 0 100 0 
Mix the tubes carefully and incubate for 24hr at 40C 
Table 4.3 cont 
Day 2 
Add the [ 1251]-mGH 
When a new batch of label is made the amount required to give 40% binding with 
0 dose of exogenous GH is determined and noted. 
Dilute the label in assay buffer to give the concentration which gives 40% binding 
and add lOOp.l to all the tubes. 
Mix the tubes carefully and incubate for 24h at 4 0C. 
Day  
Second antibody 
Sheep anti-Human IgG (SAPU) lml aliquots (From the Scottish Antibody 
Production Unit, Law Hospital, Carluke) 
Make up a solution in assay buffer containing and-human IgO (1:20). Add lOOsl 
to each tube except TC, mix, and incubate overnight at 4 0C. 
Day  
Centrifuge at 2500- 3500 rmp for 15 minutes 
Make up 10% starch solution and add to each tube except TC, and centrifuge at 
2500-3500 rmp for 15 minutes 
Aspirate the supernatant very carefully and count the pellet on the gamma counter 
linked to Assay ZAP 
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4.3.1.4 Statistical Analysis 
Estimates of likely GH levels in the plasma were taken from the literature and 
concentrations for the standard curves chosen to enable measurement of values in that 
range. This range underestimated the actual concentrations, so many values for 
which all that was known was that they were greater than 400ng/nil were found. This 
cut off in values gave a sample distribution that was not normal. Consequently it was 
decided to analyse the data using the Mann-Whitney rank order test which compares 
the rank order distribution of two sample populations. First the median of each is 
found, in a normally distributed populations the median would be the same as the 
mean. However the median is less influenced by the presence or absence of extreme 
values than the mean. Then both sets of data are ranked together and a t-test 
performed on the rank values of the two populations, to determine if distribution of 
rank values is the same in both populations. Values which tie are all given the mean 
rank value, for example if there three identical values which could be given ranks 3,4, 
or 5, they would all be given rank 4. The test was carried out using the Minitab 
statistical package. For the purpose of analysis values for which only the minimum 
of a range was known were recorded as that minimum. The results of the analysis are 
shown in Table 4.4. 
Some samples were lower in volume than required for the assay. A known 
volume of these was taken and diluted up to the same volume as the rest of the 
samples. This meant that concentrations, in the sample, of greater than 400ng/ml 
could be accurately measured because a diluted specimen was being assayed. Low 
line mice are smaller than high line mice, and have a lower blood volume. Thus the 
low line had a higher proportion of small sample volumes than the high line. This 
will have distorted the analysis by giving the low line more high rank values than 
would have been case if all samples had been the same size. To check the importance 
of this possible bias the Mann-Whitney test was repeated with all values greater than 
400ng/ml replaced by 400ng/ml. The results of this analysis are shown in table 4.5. 
GH concentration was also plotted against rank number to give a visual indication 
of the differetices between the lines and the different ages. For the purpose of the 
figures rank numbers were assigned randomly in the event of a tie (Figures 4.9 to 
4.12). 
4.3.2 Results 
The between line comparisons show that Low line mice had a higher median 
concentration of Plasma GH at all ages sampled except for 10 weeks (Table 4.4) 
This difference is significant even after all values greater than 400ng/ml have been 
replaced by 400ng/ml to avoid upwards bias for the low line because more of its 
samples were assayed after dilution (Table 4.5) . The difference between the lines 
appears to reduce with age (Table 4.4, 4.5). 
The proportion of samples with concentrations greater than 400ng/ml (known or 
otherwise unknown) rose with age. The fractions of samples with greater than 
400ng/ml were approximately, 15 01o, for four week old mice, 40% for 5 and 7 week 
old mice, and 57% for 10 week old mice (Figure 4.7 to 4.10) . This would suggest 
that GH concentrations increase with age. 
The large number of samples with Gil concentrations greater than or equal to 400 
ng/ml explains why this is the commonest median value found (Tables 4.4, 4.5). 
4.3.3 Discussion 
The results indicated that Plasma GH concentrations are lower in the mice 
selected for high body weight than in those selected for low body weight. This would 
Table 4.4 
Median Gil concentrations in ng/ml for the High and Low P-Line mice at 
several ages. The Mann -Whitney rank order test (minitab) was used to test the 
null hypothesis that the two populations did not differ in Plasma OH 
concentration. Concentrations measured as ' 2! ' a value recorded as the value, 
other concentrations as measured. 
Low Line median High line median Significance of 
(ng/ml) (ng/ml) difference 
4 week old 	233.8 94.2 ** 
(number of samples) (12) (35) 
5 week old 	486.0 156.4 ** 
(number of samples) (13) (31) 
7 week old 	~!400.0 219.0 ** 
(number of samples) (17) (29) 
10 week old 	2t400.0 2!400.0 NS 
(number of samples) (16) (29) 
** PC 0.01, * pc0.05, NS non significant 
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Table 4.5 
Median GH concentrations in ng/ml for the High and Low P-Line mice at 
seven! ages. The Mann -Whitney rank order test (minitab) was used to test the 
null hypothesis that the two populations did not differ in Plasma GH 
concentration. All concentrations measured as over 400 ng/ml altered to 
400ng/ml. 
Low Line median High line median Significance of 
(ng/ml) (ng/ml) difference 
4 week old 	233.8 94.2 
(number of samples) (12) (35) 
5 week old 	~!400.0 156.4 * 
(number of samples) (13) (31) 
7 week old 	~!400.0 219.0 * 
(number of samples) (17) (29) 
10 week old 	2!400.0 ~t400.0 NS 
(number of samples) (16) (29) 
** pc 0.01, * pc0.05, NS non significant 
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GH concentration in plasma samples from 4 week old high and low P-Line mice. 
The assay could not measure concentrations greater than 400 ng/ml, hence this is 
a minimum value. Some values higher than this were recorded from samples 
with lower volumes than the 200 p.1 required, which were consequently diluted to 
give a sufficient volume. Samples from both lines were placed in rank order of 
increasing concentration. Where samples from different lines had the same 
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GH concentration in plasma samples from 5 week old high and low P-Line mice. 
The assay could not measure concentrations greater than 400 ng/ml, hence this is 
a minimum value. Some values higher than this were recorded from samples 
with lower volumes than the 200 p1 required, which were consequently diluted to 
give a sufficient volume. Samples from both lines were placed in rank order of 
increasing concentration. Where samples from different lines had the same recorded 
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Figure 4.11 
OH concentration in plasma samples from 7 week old high and low P-Line mice. 
The assay could not measure concentrations greater than 400 ng/ml, hence this is 
a minimum value. Some values higher than this were recorded from samples 
with lower volumes than the 200 ril required, which were consequently diluted to 
give a sufficient volume. Samples from both lines were placed in rank order of 
increasing concentration. Where samples from different lines had the same recorded 




GH concentration in plasma samples from 10 week old high and low P-Line 
mice. The assay could not measure concentrations greater than 400 ng/ml, hence 
this is a minimum value. Some values higher than this were recorded from 
samples with lower volumes than the 200 p1 required, which were consequently 
diluted to give a sufficient volume. Samples from both lines were placed in rank 
order of increasing concentration. Where samples from different lines had the same 
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agree with work in high growth mice (due to a major gene) which found that they had 
lower levels of plasma OH and higher levels of plasma IOF-I than unselected controls 
(Medrano, a al, 1991) and from work in chickens which found that broiler chickens 
had lower plasma GH levels than egg layers (Burke and Marks, 1982). As the lines 
show divergent growth from shortly after the point at which they become responsive 
to OH, and this is the age at which IOF-I secretion becomes OH inducible (Mathews, 
a al, 1988) the growth curves shown in Figures 4.4 and 4.5 are consistent with the 
suggestion that the high P-Line mice have higher levels of IGF-I than the low line. It 
is not conclusive since the increased growth at day 18 could also be explained by 
mice feeding directly on pellets rather than on milk. However work on these lines 
has already indicated that they do not differ significantly in basal IOF-I levels at 5 
weeks old, that is, during the period of rapid growth. Basal levels do differ 
significantly between the lines at 10 weeks of age, with the high line having higher 
IGF-I levels. (McKnight and Goddard, 1989). This suggests that selection in the 
P-Lines has not produced a situation analogous to that found by Medrano a al 
(1991). 
Although the results are suggestive, no concrete conclusions can be drawn from 
these results, primarily because the assay as used did not measure high enough 
concentrations. Also the samples had been stored in a -60°C freezer for three years 
waiting for the assay to be developed which may have affected the samples. 
Apparently the main problem in developing the assay was using the material from the 
first and second elution peaks from the 0100 column in the assay. These contained 
trimers and dimers of radioactive OH, which did not bind to the antiserum (Chris 
Goddard, Personal Communication). It would be useful to repeat the experiment with 
a different range of d LLL6 '' to discover if similar results can be obtained. Such a 
repeat assay might also show whether OH levels drop with age as is normally the case 
(Slabaugh a al, 1982). 
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Chapter 5 
Introduction of little dwarfism into the P-Lines 
5.1 Introduction 
The high and low body weight P-Line mice responded similarly to injections of 
rbGH (chapter 3) but appeared to differ in plasma concentrations of OH with the high 
line having lower concentrations than the low line at 4, 5 and 7 weeks of age (Chapter 
4). Plasma IGF-I levels are not significantly different at 5 weeks, although the high 
line has more ]OF-1 at 10 weeks (McKnight and Goddard, 1989). It is possible that 
that the lines differ in responsiveness to IGF-I levels. Transgenic animals with high 
concentrations of OH only show high rates of growth after IGF-I has become OH 
inducible (Mathews a al, 1988) and mice become responsive to exogenous OH at 
approximately 14 days of age (Borrelli et a!, 1989). This suggests that the increase in 
rate of weight gain observable in both lines at approximately 1 8Aof age (Figures 4.3 to 
4.5) may be due to IOF-I release becoming OH inducible. The difference in the 
magnitude of the increase between the lines may be related to differences in 
responsiveness to bE-I. This could lead to the proportional response to exogenous 
OH noted earlier. 
OH release is pulsatile and the difference in the pattern of release between males 
and females appears to be responsible for part of the sex related differences in growth 
rates and adult body weights (Robinson and Clark, 1987). Such differences in 
secretory pattern might be involved in the size difference between the lines but would 
not necessarily be observable with the assay, as only one sample was taken per 
mouse. Neither would response to exogenous rbGH in the trials I carried out earlier 
necessarily differ between the lines as the timing of the injections did not mimic a 
natural pattern of secretion. 
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Removal of GH would block that fraction of JOE-I secretion which is OH 
inducible. It would also prevent the expression of differences in the pattern of OH 
release. Consequently if either, or both, are involved in the difference in growth and 
final body weight between the lines removal of OH would reduce the difference. 
One way of removing growth hormone would be to backcross a gene for 
disrupting OH metabolism into the lines. This has already been successfully carried 
out with the backcrossing of hypopituitary dwarfism (dw) into lines of mice selected 
for high or low body weight (Pidduck and Falconer 1978); animals with this mutation 
lacks OH and prolactin and have reduced levels of thyrotrophic hormone. Their 
study found mice selected for high growth rate grew faster than those selected for low 
growth rate even in the absence of OH, i.e. in the dwarfs. However the reduction in 
growth rate as a result of substituting the dw gene was greater in the large strain than 
in the control or unselected strains. This indicated that OH was involved in the 
differences but was not the sole factor (Pidduck and Falconer, 1978). Similar results 
might be obtained with the P-Line mice. The dwarfs would also provide a OH free 
stock in which to test further the effects of rbGH. It is possible, for example, that a 
difference in responsiveness would be detectable without the masking effects of 
endogenous OH. 
5.1.1 Assessment of the sample size required 
The number of mice needed were calculated by the method used previously in 
chapter 2. The following assumptions were made. injection of OH into lit/lit mice, 
would give increases in final weight similar to those from previous work, that is 2 or 
3 g. It was also assumed that untreated little mice would have a final weight at the 
end of the experiment of lOg. From previous work the standard deviation of the 
mean male mouse weight was 0.4g (with n=15, Table 3.2). If the number of lit/lit 
bred were small and females had to be used as well as males the variability would be 
ir 
greater, so a population standard error of ig was assumed. 
Thus to identify a difference between the means, 5 of 2g (or 20%) with 
probability , P=0.95, at a significance level 0.95 and a standard error between 
population means, a, of ig (or 10%) using a two tailed test a sample size, n, was 
needed where 
n=M x 2 x 
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where M is a multiplier related to the significance level and probability of detection 
required. In this case M=13.0 (table 6.14.1, p104, Snedecor and Cochran). 
so n=(13x2x 102)1202 
n=6.5 
Rounding up, and adding one for safety gave a sample size of 8 per treatment 
group. 
To generate this number of mice a mean litter size equivalent to that of the low 
line was assumed. This was reasonable, as although the number of pups in live born 
litters was greater in the high line, the high line had greater problems of infertility. 
This gave an average litter size of six pups. Heterozygotes would have been mated to 
produce the lit/lit mice for experiment, giving the probability of any one pup being 
lit/lit as 1/4. Thus the minimum number of matings required to produce 16 mice was 
161(6 times 0.25), which rounded up to 11 matings. 
The males to be used had already been test-mated to identify which were 
heterozygotes, the females were of unknown genotype. These factors had to be 
included in the calculation of the number of matings needed. The assumption of a 
litter size of six pups was made, as above. A female, sired by a known heterozygote 
onto a wild type dam, had a 50% chance of being a heterozygote. However testing 
79 
would not have identified even all females which produce litter for by chance there 
may have been no lit/lit pups born to a heterozygous dam. The chance that a pup 
born to a pair of heterozygotes was of normal phenotype is 3/4. The chance that all 
six in a "standard" litter were phenotypically normal was (3/4)6.  Thus the chance that 
an unknown female was shown after mating to be lit/+ was 
Ch * (1-Cf ) 
= 0.5 * (1(3/4) 6 ) 
= 0.41 
Where Ch  is the probability that the female is a heterozygote and C f is the probability 
that the female was a heterozygote and was not identified as such. 
Thus in order to have 11 heterozygote by heterozygote matings to produce the 
lit/lit mice for measurement and OH treatment, 11/0.41= 27 (after rounding) matings 
had to be set up between heterozygous males and unknown females. This assumed 
no infertility problems, and, so far as possible, more matings were used. Assuming 
half of the mice born were female the 27 females needed for these mice could be 
generated from 9 matings with avenge litter size of 6 mice. Thus each backcross 
generation should have contained at least 9 usable matings where possible, 
5.2 Materials and Methods 
The backcrossing was started using 6 lit/lit mice on a C57/3L6J background, 
from the stocks normally maintained in the mouse house. They were 3 adult females, 
which had already had one litter each, and 3 adult males which had not previously 
been mated.. The P-Line mice used throughout the backcrossing program were 
surplus stock that had failed to be selected. Infertility was known to be common in 
lit/lit males (Eicher and Beamer, 1976). This infertility was not present in lit/lit mice 
expressing a growth hormone transgene (Hammer, Palmiter and Brinster, 1984) 
which suggested that treatment with OH might improve fertility. There was also a 
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three to four fold size difference between lit/lit males and high P-Line females. 
Female lit/lit mice grow with pregnancy, so the difference was less pronounced 
(Beamer and Eicher, 1976). To increase the size and, hopefully, improve the fertility 
of the lit/lit males they were treated with rbGH at 9g rbGHf g body weight/ day, 
injected subcutaneously shortly before the start of the dark period, for 21 days. This 
was the same regimen as that used to treat normal P and F Line mice. 
Two lit/lit females were 	mated to a high P-Line male, the thrL: to a low 
P-Line male, while two lit/lit males were 	mated to a low P-Line female, the 
to a high P-Line female. The largest, after GH treatment, of the 3 males was 
chosen to be mated to the high line female, however he was still less than half her 
size. All low line matings successfully produced offspring as did the two high line 
male by lit/lit female matings. The high line female by lit/lit male mating did not. 
Consequently there will be Y chromosome material from the C57 black 61 
background in the low line, but not in the high line. This is unlikely to have affected 
results due to the limited amount of genetic information coded on the Y chromosome. 
All offspring from the first litters of these matings were used in the first backcross 
matings. Second and subsequent litters were kept to provide a source of known 
heterozygous females for test-matings. For the backcross each female was mated to 
one P-Line male and each male harem mated to two or three P-Line females. This 
maximised the number of litters. There were 10 matings for each line, all produced a 
litter in the high line, one proved infertile in the low line. 
The general pattern of the backcrossing, up to the third generation, is shown in 
Figure 5.1 . Males were chosen randomly within family to be test-mated to a known 
heterozygous female, at between 6 and 7 weeks of age. All test-matings were set up 
at the same time. The number of males tested was limited to between 12 and 15 per 
line, equal numbers in each, by the number of heterozygous females available. The 
Figure 5.1 
Backerossing of lit/lit dwarfism into P-lines 
lit/lit x GPH/L 
	
Fl x GPH/L 	 (Fl - 0.50) 
(Fl x ) B 1 x GPH/L 	 (B1-O.75) 
T1 
(Fl x) B2 x GPH/L 	 (B2 - 0:83) 
T2 
(Fl x)B3 	 B3 x B3 	(B3-0.91) 
T3 	 H2 
The numbers in brackets indicate the theorectical proportion of P-Line 
genetic background at sites unlinked to the little gene. 
Ti, T2, and 13 are testcrosses 
H2 is the mating between lit/lit offspring of B3 to produce mice for the 
trial of the effects of GH, as described in section 5.2.1 
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males were removed after 18 days and each was harem mated to 2 or 3 of the 
appropriate P-Line females. This resulted in between 30 and 35 matings per line, 
numbers again being limited by the availability of females. 
BP expanded diet number one (special diets services, Witham Essex, UK.), and 
water were available ad libitum as in the previous experiments. Pups were identified 
individually by toe clipping, and weighed daily throughout the nursing period. Litters 
from all matings were weaned at 21 days of age, mash was provided if any pups were 
particularly small. This ensured that small mice had access to food and water even if 
they could not reach the normal food and water containers. The sexes were segregated 
at weaning. 
Pups in litters from test-matings were weighed daily from weaning at 21 days 
until 24 days, to record any growth check at weaning. They were then weighed 
weekly from 4 to 6 weeks of age. Mice that were clearly ill at any stage were killed 
to prevent false identification as lit/lit, which resulted in large losses in backcrosses 2 
and 3 when rheo virus and sendai virus infected the mouse house. Any litters 
containing mice noticeably smaller than their sibs were analysed further. The small 
mice were segregated into one group and their sibs into another. No distinction 
between the sexes was made. Analysis of variance was then carried out on the two 
groups to determine if they were significantly different at the 5% level. Litters in 
which a significant result was obtained were deemed to have been sired by a 
heterozygote. If no lit/lit mice were apparent at six weeks of age the sire was deemed 
homozygous wild type and he, and the litters he had sired on P-Line females, were 
culled. This method of distinguishing lit/lit mice is biased as only litters which 
appear to contain small mice are analysed. The bias is not important providing mice 
identified as lit/lit are little. The accuracy of this method was checked in the third 
backcross generation test cross by ranking the mice by increasing order of 42 day 
weight within line by genotype and sex groups (for example Wild type high line 
am 
females). Weight was then plotted against ranking. 
The mice used could not be treated with GH from 4 to 7 weeks of age, unlike the 
mice in the previous trials, as it is often not possible to distinguish lit/lit mice from 
heterozygous litter mates until they reach 6 weeks of age. A period to adapt to the 
controlled light regime was necessary and consequently the treatment period used 
was from 7 to 10 weeks of age. 
5.2.1 Replacement matings 
Due to the deaths from the rheo and sendai viruses there were too few lit/lit mice 
from the first litters of matings of the third backcross generation to give the sample 
sizes required. In an attempt to remedy this the lit/lit offspring were mated together 
within line (the 112 matings). These mating were set up at the same time as the 
heterozygote matings were set up again. Very small sample sizes resulted (Table 5.1) 
but the experiment was performed in the hope that enough information would be 
obtained to indicate whether or not to maintain the lines in the hope of repeating the 
experiment with reasonable sample sizes. This was subsequently carried out (chapter 
6). 
Lit/lit mice were assigned randomly within family to treatment groups at 6 weeks 
of age. Mice from one sex, line and treatment group were caged together. This 
confounded any cage effects with treatment effects but reduced the risk of a mouse 
being accidentally injected with saline instead of GH, or vice versa. Wild type males 
from the heterozygote by heterozygote matings (that is full sibs of some of the lit/lit 
mice) were chosen as controls. The experimental animals were maintained in 
controlled light conditions (14 hours light, 10 hours dark) from 6 weeks of age. 
Treatment started at 7 weeks, to allow time to recover from the transfer and adjust to 
the controlled light conditions. Food and water were freely available ad libitu,n. The 
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Table 5,1 
Preliminary trial of OH on lit/lit mice 
Numbers of mice per group 
0.1 ml Saline/20g/day 	9j.tg GH/g/day 
Low line males 	 3 	 3 
Low line females 	 4 	 4 
High line males 	 3 	 3 
High line females 	 3 	 4 
M. 
lit/lit mice were injected daily from seven to ten weeks of age with OH at 9jsg/g/day 
or saline at 0.5p.lIg/day in the two hours before the start of the dark period. They 
were weighed immediately before injection. After all the lit/lit mice had been 
injected the wild type mice were weighed. Dissection and freeze drying were not 
carried out, due to the small sample sizes. 
5.3 Results 
Examination of six week weights suggest that each group of putative wild type 
mice contains one or more mice which are substantially smaller than the others 
(Figure 5.2, 5.3) . This is particularly apparent for the high line males with weights of 
less than 12g (Figure 5.2), and the low line female with a weight of less than 8g 
(figure 5.3). These animals may have shown reduced growth due to ill health or 
maternal effects, but may also be lit/lit mice that were not identified by the 
classification used. All the putative lit/lit mice fall within a weight range of 4g 
(Figures 5.4, 5.5) and at least 2g less than the minimum weight of the main block of 
wild type values for each line and sex group (Figures 5.2 to 5.5). This suggest no 
wild type mice have been identified as dwarfs. 
No mice were removed from the calculation of mean daily preweaning weights 
because of doubts about theft correct genotype. All line and genotype and sex groups 
appear to show similar growth rates until weaning, at which point wild type mice 
from both lines show a definite increase in growth rate as do the high line littles 
(figures 5.6, 5.7) . Such an increase is less apparent in the Low Line littles, if indeed 
it exists. The growth of littles from the high line is similar to the growth of wild type 
mice from the low body weight line (Figure 5.6, 5.7). Indeed, in females the curves 
are almost superimposed (Figure 5.7). 















6 week weights of high P-Line putative wild type mice plotted 
against the rank number. The mice were the offspring of the test 
mating of the third backcross generation and were ranked in increasing 
order of weight. 
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Figure 5.3 
6 week weights of Low P-Line putative wild type mice plotted 
against the rank number. The mice were the offspring of the test 
mating of the third backcross generation and were ranked in increasing 
order of weight. 
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6 week weights of high P-Line putative lit/lit mice plotted against the 
rank number. The mice were the offspring of the test mating of the third 
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6 week weights of low P-Line putative lit/lit mice plotted 
against the rank number. The mice were the offspring of the test 
mating of the third backcross generation and were ranked in 
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Figure 5.6 
Mean daily weights of male putative wild type and lit/lit P-line mice 
from birth to 42 days of age. The mice are the offspring of the test 
matings of the third generation backcross. The error bars give the 
maximum standard errors of the means. 
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Mean daily weights of female putative wild type and lit/lit P-line mice 
from birth to 42 days of age. The mice are the offspring of the test 
matings of the third generation backcross. The error bars give the 
maximum standard errors of the means. 
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from both lines which were injected with rbGH have gained more weight over the 
treatment period than those injected with saline (Figure 5.8, 5.9) . Also the weight 
gain of treated mice was substantially higher than that of the uninjected wild type 
mice over the same age range. In the High line lit/lit mice gained approximately 11 g, 
untreated wild type mice approximately 5g. For the low line the figures were 
approximately 5g and approximately ig respectively (Figures 5.8 to 5.11). High line 
littles appeared to gain two to three times as much weight as low line littles over the 
treatment period, regardless of treatment (figures 5.8, 5.9). There appears to be a 
difference between the sexes in response of lit/lit mice to rbGH, this may be an 
artifact due to the small sample sizes (Figures 5.8, 5.9). The growth data of the little 
mice over the period of treatment with OH or saline lacks error bars because the 
sample sizes were too small to enable meaningful errors to be calculated (Figures 5.8, 
5.9) due to the deaths caused by the rheo and sendai virus infections. For this reason 
no statistical analysis was performed on the results. 
5.4 Discussion 
The unusually small mice in the wild type type group may be misclassified littles 
or small as a result of an unidentified infection. Some misclassification would have 
been expected to happen, regardless of the method chosen to distinguish between the 
two types of mice, as no method is error free. In this experiment it was more 
important to be sure that every mouse identified as lit/lit was indeed a dwarf than it 
was to identify every such animal. This conservative, ensured sires used in the 
backcrossing carried the lit gene and that sick animals, which might respond 
differently to treatment, were not used in the investigation of the effects of exogenous 
(JR. Although the sample sizes are smaller, the limited range of weights observed, 
and the absence of overlap between little weights and the main group of wild type 
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Figure 5.9 
Mean daily gains of female lit/lit mice injected with 9sg GH/g body 
weight /day or with 5gl saline/ g body weight/ day for 21 days from 
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Figure 5.10 
Mean daily gains of male P-Line mice from 7 to ten weeks 
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dwarfs. The faster absolute growth rate of littles from the high lines suggests that 
selection has not acted on responsiveness to OH, but to some other factor. Due to 
scale effects the relative proportionate increase would be more informative, this was 
calculated in chapter 6 but was inappropriate here due to the large standard errors. 
The previous plot of mouse weight against age (Figure 4.3 to 4.5) showed an 
increase in growth rate in wild type mice from both lines, starting from about 18 days 
of age. As mice appear to become responsive to GH shortly before this age (Borrelli 
et al, 1989) it appeared possible that this induced the increase in growth rate. If this 
was the case then lit/lit mice should not show such an increase in growth rate at 18 
days old, regardless of line. However, lit/lit mice from the high line clearly show 
such an increase in growth rate (Figures 5.6, 5.7). The evidence is less clear for the 
low line littles. This suggests that OH, or response to it, is not solely responsible for 
the increased rate of gain. However the increase in the little mice is not as substantial 
as that observed in wild type mice which suggests that OH has some effect, possibly 
amplifying the effect of some other factor. This factor could have been increased 
food intake as mice begin to eat the pelleted food available at about 18 days of age 
(personal observation). Certainly low line pups crossfostered onto high line dams 
showed greater preweaning growth, suggesting that for the low line at least, food 
supply has a limiting effect on growth (Figure 4.5). Given that high line mice were 
larger at birth than low line mice the factor responsible for the thfferencweights 
may be an in utero effect. 
After removal of GH by backcrossing in the little gene the mice responded to 
exogenous OH with increased growth. The difference in the absolute weight gained 
between littles treated with OH and controls was greater in the high line than in the 
low line but given the small sample sizes the analysis of proportionate gain was 
delayed until larger sample sizes were available (Chapter 6). As high line lit/lit mice 
were also heavier than low line lit/lit mice at the start of treatment this suggests that 
the proportional difference in response noted in chapter 3 exists despite the removal 
of GH. (A difference in body weight at the start of the experiment between little mice 
from high and low body weight lines was not noted in chapter 6, which covered an 
earlier age range). Also saline controls from the high line littles grew faster than the 
those from the low line, suggesting differences between the lines are not related 
solely to OH. Due to the sample sizes no firm conclusions could be drawn, but the 
results indicate that it would be useful to maintain the lines and repeat the experiment 
with larger samples. This would enable statistical analysis of the results and 
investigation of the effects on carcass composition. In the wild type mice, the greater 
gain of the high line mice may indicate that they continued to grow over a longer 
period than the low line mice. 
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Chapter 6 
Effects of exogenous GH in GH deficient little mice 
6.1 Introduction 
The growth of high and low body weight mice suggested that the removal of GH 
affected both lines in proportion to their body weight. Ability to respond to 
exogenous rbGH also remained similar between the lines. However the sample sizes 
used were too small to enable conclusions to be drawn with any degree of certainty, 
due to the high number of deaths after rheo and sendai virus entered the animal 
house. Thus it was decided to repeat the treatment with larger sample sizes including 
wild type P-Line mice for comparison purposes. 
I was not able to continue breeding the mice, or perform the experiment because 
of time constraints. I gave assistance with the design of the experiment, performed 
some of the injections and weighing and ran the resultant data through the "Harvey" 
statistics program to check the analysis. I also made some contributions to the 
interpretation. However most of the work was performed by Dr Ian Hastings. 
6.2 Materials and Methods 
The maintenance of the Little lines of mice was taken over by Ian Hastings. The 
breeding program was altered, primarily for ease of handling. As the new schedule 
involved large numbers of lit/lit by lit/lit matings it was also easier to generate 
animals of known genotype for experimental purposes. In the new program 16 
families were set up per line in each generation. One male and one female were taken 
from each family as parents of the next generation. Each backcross generation was 
followed by four generations of within line mating before the next backcross carried 
out. The backcrossing transmitted alterations in gene frequency, and any new 
mutations from the P-Lines to the little lines. The subsequent within line matings 
meant that only one in 5 generations produced a mixture of wild type and little mice. 
This reduced the number of mice that had to be maintained, and also meant that only 
one generation had to be weighed to distinguish between wild type and little mice. 
The offspring of the first within line mating after each backcross, that is the 
offspring of two heterozygous parents, were weighed at 6 weeks to enable 
identification of lit/lit mice. The weights also provided useful data for the 
comparison of wild type and little mice. Wild type and lit/lit mice were distinguished 
by using the weights of mice obtained in the generations previous to the change in 
breeding protocol. These indicated that at 6 weeks of age, High Line lit/lit mice 
should weigh less than 18g. and Low Line lit/lits less than lOg (Figures 5.4, 5.5). All 
ill mice were assumed to be wild type to avoid misclassifying a wild type runt as a 
dwarf. 
The little mice used were taken from litters produced from homozygous lit/lit 
matings set up after the third backcross generation, that is with an average of 93% 
parental line alleles at loci unlinked to the lit gene. The wild type P-Line mice had 
been selected for 44 generations. Contemporaneous wild type and little matings were 
set up in a fixed light environment (14hour light, 10 hour dark). BP expanded diet 
no. 1 was available ad libitum both as pellets and as mash. Water was also freely 
available. All mice were weaned on the same day, at age 26 (±2) days. Mice were 
assigned randomly within family to a treatment group (GH or saline), and cage at 
weaning. All mice in a cage were given the same treatment to reduce the chance of a 
mouse receiving the wrong injection. Each cage contained mice from all four lines. 
At weaning there were 15 mice in each group listed in Table 6.1. Two mice were 
removed from the trial after being discovered to be misclassified females, one after 
being bitten by its cage mates, and one died. There were no apparent adverse effects 
from the injections. 
Mice were injected subcutaneously, daily from 28 (±2) days of age for 21 days. 
Injections were either 9g/g body weight/day (as a 1.8 mg/ml solution in isotonic 
bicarbonate saline) or a corresponding volume of the same saline as in chapters 2 and 
3 of this thesis, and were given between 130 and 45 minutes before the start of the 
dark period. Animals were weighed on the first day, and on mondays, wednesdays, 
and fridays thereafter. The amount to be injected was calculated from the last 
recorded weight. Saline and OH cages were injected alternately. 
After the injections the mice were killed and freeze dried. Each group was sorted 
into four sets of three individuals split across family and cage. The fat, protein 
(estimated as 6.25 times nitrogen) and ash contents of each set was determined 
chemically, by S.A.C., Edinburgh. The results were then analysed by restricted 
maximum likelihood (REML) using the Genstat statistics package. The model fitted 
high or low line genetic background, little genotype, and treatment (GH or saline) as 
fixed effects, and family and cage number. Batch of freeze drying was also included 
as a random effect where appropriate. 
I also ran the data through a mixed model least squares and maximum likelihood 
computer program (Harvey 1985), as had been used in the analysis of previous 
experiments. The results of the analysis supported those obtained from the Genstat 
package and are not shown. 
6.3 Results 
It can be seen from both Table 6. 1, and Table 6.2 that there are large differences 
in body weight between the groups investigated. The analysis of main and interaction 
effects was thus carried out on both untransfomied and natural log transformed data, 
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Table 6.1 
Weights and carcass composition for male wild type and little mice from the high and low P-Lines. 
treated with 9gg GH/g/day, or with 0.lml salinet20g/day. Means (± standard deviation) of body weight 
at 4 and 7 weeks of age, weight gain from 4 to 7 weeks expressed in grams (g) and as a percentage of 
weight at 4 weeks (%). Means of carcass traits at 7 weeks of age expressed in grains (g) or percentage of 
dry weight (%). Standard errors are avenge standard errors of group means. 
High 	 Low 
+1+ 	 At/&L- 	+1+ 	lit/lit 
	
OH saline OH saline 	GH saline GH saline 	s.e 
14 15 14 15 14 14 15 15 
4 week weight (g) 21.6 21.0 10.6 10.6 11.6 11.6 5.7 5.9 0.58 
±5.6 ±4.9 ±1.4 ±1.0 ±1.8 ±1.5 ±0.8 ±0.9 - 
7 week weight (g) 44.2 39.5 24.1 17.6 18.3 17.2 11.0 8.4 0.51 
±3.3 ±3.4 ±2.7 ±1.7 ±1.5 ±1.0 ±1.1 ±1.0 - 
gain (g) 22.5 18.6 13.5 7.0 6.7 5.5 5.3 2.5 0.41 
±2.8 ±3.5 ±1.9 ±1.1 ±1.0 ±0.8 ±0.8 ±0.5 - 
gain (%) 114 95 129 66 60 49 95 45 5.8 
±43 ±34 ±20 ±12 ±16 ±13 ±21 ±18 
water (g) 29.1 26.2 14.7 9.7 11.9 11.2 7.0 5.1 0.32 
fat (g) 3.6 3.1 3.3 3.7 1.4 1.5 1.0 1.2 0.17 
protein (g) 8.5 7.8 4.2 2.9 3.6 3.4 2.1 1.5 0.07 
ash (g) 1.4 1.3 0.8 0.6 0.6 0.6 0.4 0.3 0.16 
fat (%) 26 24 39 50 24 26 28 38 1.3 
protein (%) 60 61 49 39 62 62 57 49 1.0 
ash (%) 10 11 9 8 11 11 11 10 0.2 
* number of animals and records, of body weights, water weights and gains. 
For other traits there were four samples of pooled mice within each group 
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Table 6.2 
Main effects and interactions (± standard errors) for body weight (8W), gain, 
lean mass, and % fat at 7 weeks of age. 
Untransformed 
8W (g) gain (g) lean mass(g) % fat 
Main effects 
Background (High - Low) 17.9±0.6*** 10.2±0.5*** 3.2±0.06*** 5.5±1.1*** 
lit gene (lit/lit - +1+) 14.7±0.6*1 ..5.9±0.5*** .3.15±0.06*** 13.8±1.1*** 
treatment (GH - Saline) 3.7±0.3*** 3.6±0.2*** 0.68±0.06*** 5.5±1.1*** 
Interactions 
lit xbackground 6.7±0.9*** 3.8±0.7*** 1.42±0.08*** 5.9±1.5*** 
lit x treatment 1.0±0.6 1.1±0.5* 0.23±0.08** .50+5** 
background x treatment 1.8±0.6** 1.6±0.5*** 0.32±0.08*** 0.4±1.5 
lit x background x treatment 0.3±0.9 0.3±0.8 0.04±0.12 -1.3±2.1 
Natural log, transformed 
8W gain lean mass %fat 
Main effects 
Background (High -Low) 0.82±0.03*** 1.08±0.05*** 0.76±0..02*** 0.14±0.04*** 
lit gene (lit/lit - +1+) 	0.67±0.03*** 0.60±0.05*** 0.77±0.02*** 0,4,44*** 
treatment (GH - Saline) 0.19±0.01*** 051±0.07*** 0.20±0.02*** 0.14±0.04*** 
Interactions 
lit x background 	.0.05±0.04 	-0.11±0.07 
lit x treatment 0.10±0.03*** 0.26±0.07*** 
background x treatment 	0.02±0.03 	-0.02±0.07 





* p<O.OS, ** pcO.Ol, " pc0.001 
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to provide information on the scale effects 
At 4 weeks of age the line by background groups differed in body weight, with 
the high line being just under twice the size of the low line, whether lit/lit or wild type 
(Table 6.1). Also the little mice were approximately half the weight of the wild type 
mice. There were no significant differences in weight between the groups assigned to 
different treatments. Supporting the results from the previous chapter, wild type low 
line mice were of similar size to lit/lit high line mice (Table 6.1). 
All three factors investigated had affected body weight and gain (Table 6.2). 
High line mice were heavier than low line mice by 17.9g, and wild type mice were 
heavier than lit/lit mice by 14.7g, on average. Treatment with OH increased body 
weight by an average of 3.7g. (Table 6.2, untransformed data). The effects of all 
these traits remained significant after correction for scale effects by natural logarithm 
transformation (Table 6.2, transformed data). Significant interactions were observed 
between the little gene and genetic background, and between the genetic background 
and treatment for 7 week weight, and for gain in grams, on the untransformed data 
(Table 6.2). However these were non significant in the transformed data, indicating 
that the lines respond proportionately to the removal, or addition, of GH (Table 6.2). 
The interaction between little genotype and OH treatment was significant only in the 
transformed data suggesting that little mice respond to OH treatment with a greater 
increase in weight, for their size, than wild type mice. 
Lean mass and fat percentage were also affected by all three traits investigated, 
and significant effects were observed in the transformed and in the untransformed 
data. Averaging over wild type and lit/lit mice the high line had a lean mass 3.2g 
heavier than the low line, and were also 5.5% fatter (table 6.2, untransformed data). 
This suggests that the selection procedure used has not been entirely successful in the 
goal of increasing lean mass, while maintaining body composition unchanged. 
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Them were also significant interactions which remained after transformation, 
between the little gene and genetic background, and between the little gene and GB 
treatment for both lean mass and fat percentage (Table 6.2), although the interaction 
with treatment for the fat percentage becomes smaller after transformation. Protein 
content (g) measures lean mass, and high line mice lose a greater proportion of their 
protein when GB is removed by backcrossing the little gene (approximately two 
thirds) than do low line mice (approximately half) (table 6.1, comparing untreated 
mice). Fat percentage in high line littles was approximately double that in wild types, 
while in the low line it was only approximately 50% greater. Lit/lit mice had a 
smaller lean mass and greater fat % than wild type mice. Treatment with GB had 
greater effects on increasing lean mass and decreasing fat content in littles than in 
wild type mice (Table 6.1) 
6.4 Discussion 
Selection on high and low body weight in these lines has not solely affected the 
OH axis. Indeed it appears that as far as final weight and weight gain are concerned 
the growth hormone axis has not been affected, as there is no interaction between 
genetic background and little genotype, or between genetic background and 
treatment. This is in contrast to the results obtained by Pidduck and Falconer (1978) 
who found that when the dw dwarfism gene was backcrossed into lines selected for 
high and low growth rate the reduction in growth rate was greater in the high selected 
line than the low line. Also dw/dw mice from the low selected line were less 
responsive to exogenous OH suggesting that GH levels and responsiveness to OH had 
been altered by selection (Pidduck and Falconer, 1978). There is a suggestion that 
low P-Line mice stop growing at a younger age than High P-Line mice (Figure 4.6), 
which may indicate differences between the lines at later ages. 
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There does however appear to have been some effect on partitioning. The effects 
on fat percentage of the removal of GH, and its exogenous administration were 
probably explicable by the lipolytic effects of GH (Fielder and Talamantes, 1992). 
Why there should be an interaction with line genetic background is unclear. 
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Chapter 7 
Effects of Treatment with antiserum to rat OH 
7.1 Introduction 
Backcrossing the little gene into the P-Lines of mice was designed to repress OH 
production and release, by preventing somatotrophs from responding to GHRF 
(Jansson et al, 1986). Consequently in lid lit mice OH was effectively absent 
throughout development, whereas in normal mice it is expressed from embryonic day 
16 (Slabaugh et al, 1982). This absence may well have effects on the development of 
other parts of the endocrine system. Support for this idea was given by the loss of 
first litters of lit/lit females, and the poor performance of lit/lit males in siring litters 
(Eicher and Beamer, 1976). It seemed possible that further information on the 
activities of growth hormone itself might be obtained if the OH could be selectively 
removed for a defined period of growth. 
A possible way of removing the GH was by use of an antiserum to GH. In rats, 
treatment of 35-40 day old males with goat anti-rat GH (anti-rGH) over a 6 day 
period resulted in reduced body weight gain (Gause, Eden, Jansson, and Isaksson, 
1983). A single injection of sheep anti-rGH into 28 day rats temporarily reduced the 
rate of body weight gain, an effect which was prevented by simultaneous injection of 
ovine GH (Flint and Gardner, 1989). Later work showed that 35 day male rats 
injected with sheep anti-rGH serum could be separated into two categories. One 
group rapidly recovered from the anti-rGH, and their subsequent growth curve 
paralleled that of the untreated control groups. The other group had a very low 
weight gain for several weeks, before recovering. Again the subsequent growth curve 
paralleled that of the controls of the same age, there was no catch up growth (Macion, 
Parton and Flint, 1991). The difference appears to be due to differences in the rate of 
removal of the injected sheep antisera from the blood stream (Madon et al, 1991). 
The experiments described in this chapter were designed to investigate ir similar 
effects could be discerned in the mouse and furthermore to investigate any 
interactions with line genetic background. 
Rats given a single injection of sheep anti-rGH at 2, 10, or 20 days old continued 
to grow at the same rate as control rats injected with normal sheep serum or saline 
(Flint and Gardner, 1989). In addition, rats given normal sheep serum and ovine OH 
at 2, 10, or 20 days of age continued to grow at the same rate as saline controls. Rats 
given the same treatment at 28 days had an increased rate of body weight gain (Flint 
and Gardner, 1989). These results suggested that, although OH is present in the rat 
from before birth (Walker, Dussault, Alvardo-Urbine and Dupont, 1977), it may have 
limited effects on growth before thy 20. However, repeated injections of 2 day old 
rats with sheep anti-rGH resulted in long term reductions of growth (Flint and 
Gardner, 1989), This reduction was temporarily reversible by injections of ovine OH 
(Hint and Gardner, 1989), and appeared to be due to destruction of somatotrophs in 
the pituitary as there was a reduction in pituitary size and in the release of OH in 
response to exogenous OH releasing factor (Gardner and Hint, 1990). This suggests 
that antiserum administration in the mouse should be carried out after weaning to 
avoid such complications as limited effects of reduction in OH levels prior to this age, 
or to the destruction of the somatotrophs. 
The sera available were sheep anti-rat OH (anti-rGH), therefore a preliminary trial 
was carried out to determine whether they were active in mice. 
7.2 Preliminary Trial 
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7.2.1 Materials and Methods 
Excess mice from the backcrossing programme were used in this preliminary trial 
as there were mice of a suitable age available. Males had been mated to females of 
the appropriate P-Line before theft genotype was known, some were not shown to be 
heterozygous 11:1+. Offspring of such males, from generation BI of the backcross, 
were used in this preliminary trial. On average theft genomes were 83% P-Line. Test 
matings would not identify all litI+ males, and thus there may have been lit/+ males 
in the test groups. For a preliminary trial this seemed unlikely to be important, in 
particular as the little allele is recessive to the wild type in its effects on growth 
(Eicher and Beamer, 1976) 
The antisera used, sheep anti-rGH, were kindly donated by D. Flint, R. MacIon 
and D. Parton (Hannah Research Institute, Ayr, Scotland) as dried whole serum and 
diluted with distilled water before use. They had been raised by injecting rat growth 
hormone into five different sheep and had been prepared as described by Madon et al 
(1986). The sera obtained were numbered with the same code as the sheep from 
which they came. They were ranked by in vivo tests in rats as 9>>> 854> 817> 879 
> 880, that is the serum from sheep, code 9, was much the most effective in rats 
(Flint, Madon and Parton, personal communication.). All the sera were used, for this 
preliminary trial, as it was possible they would differ considerably in effectiveness in 
mice. 
The mice were 35 days old at the start of treatment. For simplicity it was 
assumed that all the mice weighed approximately 20g, and doses were given per 
mouse rather than per gram body weight. Two doses were used in low line mice, one 
of antiserum at a dose per mouse similar to that given to the rats, and one at twice that 
concentration. Insufficient high line mice were available for both dose levels to be 
tested, the higher dose was tested in this line as the mice were bigger than the 20 
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grams assumed. There was also a control group given normal sheep serum at the 
same concentration as the higher dose in both lines. Serum was used as control rather 
than saline as it appeared possible that the injection of large quantities of foreign 
proteins could in itself affect the growth of the mice. Amount of serum given and 
number of mice per group are shown in Table 7.1. 
The animals were maintained as specified in chapter 2, although they were not 
maintained in controlled light conditions. Insufficient animals were available to 
assign one from each family to each treatment group. Consequently they were 
randomly assigned to treatment group, with the proviso that animals from the same 
family were not in the same treatment group. Animals were housed together by 
treatment group. Injections were given subcutaneously into the back of the neck at 
9am and 5pm, when the mouse reached 35 days old. This ensured that, despite a 
range of 10 days in dates of birth, the animals were of comparable ages when studied. 
Weights were recorded on a daily basis, shortly before 5pm, from the day before the 
injections until 7 days after the injections. 
7.2.2 Results 
The effects of the antiserum were not clear in the low line mice treated with sera 
at a concentration of 25j.Lg/150l (Figure (7.1) . The group injected with normal 
sheep serum did display less of a reduction of growth on the day after the injection 
than the other groups (Figure 7.1). Effects were even less clear in the high line mice 
which had been injected with antiserum at 5O.tg4t1 in that some of the sera appeared 
to have had no more growth reducing activity than did the control serum (Figure 7.2) 
As the high line mice weighed approximately twice as much as the low line mice, 
these two groups received comparable doses on a per gram of body weight basis. 
Low line mice treated with 50p/R 1 did appear to react to the antisera, in that every 
group showed a temporary reduction in growth after the injection (Figure 7.3) . There 
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Table 
Numbers of mice used in 
7.1 
preliminary anti serum trial 
Serum Serum Serum Serum Serum 	Control 
817 879 880 854 9 Serum 
High Line 3 3 2 3 3 	3 
50sg/150)sl 
Low line 4 4 4 4 4 	6 
5Og/l5Op.l 
Low line 4 4 4 4 4 	- 
25g/150W 
Table 7.2 
Numbers of mice used in second anti serum trial 
	
Anti 	Control 	Saline 
Serum Serum Control 
Low line 	 10 	 10 	 10 
Only 
Table 7.3 
Numbers ofmice used in final anti serum trial 
Anti Control Saline 
Serum Serum Control 
Low line 	 7 6 6 
High line 	 11 11 11 
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Mean daily gains of the male offspring of male mice from generation B 1 of the 
backcrossing program, and low P-Line females, genotype 83% low P-Line They 
recieved two identical injections, at 9am and 5pm on day one totalling 15Osl 
solution containing either 25gg antiserum, or Sojsg normal sheep serum 
(controls). 5 different antisera were tested. Error bars give the maximum standard 
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Figure 7.3 
Mean daily gains of the male offspring of male mice from generation B 1 of 
the backcrossing program, and low P-Line females, genotype 83% low 
P-Line They recieved two identical injections, at 9am and 5pm on day one 
totalling 1501.11 solution containing either 50ig antiserum, or SOpsg normal 
sheep serum (controls). 5 different antisera were tested. Error bars give the 
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was an apparent check in growth in growth in the group given the control serum, 
although this was smaller than than that observed in the groups given anti-sera 
(Figure 7.3). These results were obtained from extremely small sample sizes, and are 
therefore suggestive rather than conclusive. On the basis of this evidence it was 
concluded that the anti-sera reduced growth in mice, at least at the higher dose. This 
suggested that a further trial, injecting mice with serum on a gsg/g of body weight 
basis would be useful. 
Due to limitations in the numbers of mice available and in the time required to 
carry out the weighings and injections it seemed advisable to only use one serum for 
further work. Serum 880 caused a noticeable reduction in growth in all three line and 
treatment combinations (Figures 7.1, 7.2, 7.3) although it was the least effective 
serum in rats. This probably reflects a species specific difference and serum 880 was 
consequently chosen. 
Low line mice given 5Ojsg4U showed reduced rate of increase of body weight 
throughout the experiment (Figure 7.3). If this difference in gain between treated and 
untreated mice was maintained for a prolonged period the magnitude of the difference 
in final weights between the lines should increase. This would increase the 
probability of identifying any differences between the lines. Consequently it was 
decided to continue weighing the mice for 21 days after the first injection. Shifting 
the first injection to when the mice were 4 weeks of age, to cover the period of 
maximum growth, and hence maximum potential to reduce growth would also 
increase the probability of finding any effects. A further way of increasing the effects 
on growth would be to give injections on more than one day. 
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7.3 Second Preliminary Trial 
7.3.1 Materials and Methods 
In the preliminary trial the effective dose had been 509g in 150 1.11, on low line 
mice, of average weight 15g, so the average dose was 3. 3jsg/g body weight in 
10 111 solution] g body weight at each injection. For simplicity of dilution a standard 
solution of 3p.g/lOjsl was used and the mice were injected with 11 
p.1 of solution] g body weight. A control group injected with saline as in chapters 2, 
3, and 6 was also added to enable identification of effects due to normal sheep serum. 
Matings were set up using mice from the P-lines, Generation 17, to provided 
contemporaneous animals from both lines for treatment with the antiserum. Due to 
disease problems in the animal house insufficient high line mice were produced by 
the matings. The low line mice were used in a second preliminary trial in order to 
observe the effects of repeating the injections. They were 28 days (±2 days) old at 
the start of the experiments. Animals were assigned within family to a treatment 
group at weaning, numbers as given in Table 7.2, but caged with their sibs to reduce 
the risk of transmission of infection. They were otherwise maintained as specified in 
chapter 2, although not in controlled light conditions. Injections were given and daily 
weights recorded as specified in the previous experiment. The mice were injected on 
days one, four, and seven of the experiment. 
7.3.2 Results 
The daily gains were as shown in Figure 7.4. Both the groups given sheep serum, 
either normal sheep serum or anti rat GH, showed some flattening of the growth 
curve on the days following the injections. These apparent reductions in growth were 
neither clear nor conclusive, given that fluctuations of similar magnitude in 
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Figure 7.4 
Mean daily gains of male low P-Line mice from 28 to 35 days old. They 
recieved two injections, at 9 am and 5pm on days 1, 4 and 7 after the start of the 
experiment, of 1 lpiJ/ g body weight each time. They recieved 3jsg/ml of 
antiserum, 3p.gfml of normal sheep serum or saline. Error bars give the 
maximum standard errors of the means. 
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cumulative daily gain were observable towards the end of the experiment, when no 
treatment was being given (Figure 7.4). This could mean that the effects observed in 
the preliminary trial were an experimental artifact resulting from the small sample 
sizes involved. However, the occurrence of such a reduction in the group treated with 
antiserum to GH, after every set of injections supported the idea that the antiserum is 
interfering with the GH pathway and that a large scale trial should be carried out. No 
adverse effects of repeated antiserum injections on the mice were detected. 
7.4 Final Trial 
7.4.1 Materials and Methods 
The mice used were the offspring of mice from the P6 Lines at generation 39. 
They were treated as in the preceding experiment, with the exception that only one 
injection was given on day 7, in the morning, due to a shortage of serum. Animals 
were not weighed on all days, due to time limitations. Their age at the start of the 
experiment was 28 (±3) days. The numbers per group were as shown in Table 7.3. 
These group sizes were not enough to permit satisfactory statistical analysis. 
However analysis was carried out to check for interactions between line and 
treatment effects. Any effects found would have to be interpreted with caution. 
Means and standard errors were calculated, and plotted. Weights and relative 
gains were analysed using a mixed model least squares and maximum likelihood 
computer program, as in chapter 2 (Harvey, 1985). Relative gains were calculated as 
natural log of final weight minus natural log of initial weight for the period in 
question. Analyses were carried out using a model with line and treatment as fixed 
cross classified effects. Family was included as a random effect. The model also 
tested for interactions between lines and treatments. The final weight, and all relative 
gains were regressed onto the natural log of initial weight to remove scaling effects 
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due to the substantial differences in size between the high and low lines 
Relative gains on days two, five, and eight, were analysed as being the days after 
one, two, or three courses of injection respectively, and hence likely times to observe 
effects. The longevity of the effects on continued gain was analysed by the relative 
gain at days fifteen and twenty-two. 
7.4.2 Results 
Significant effects of treatment on final body weight and on relative gain for the 
period of the experiment, RG(day 22), (P<O.Ol) were found, also on relative gain for 
the period from day 0 until day 15 (Pc0.05) (Table 7.4) . Animals treated with 
antiserum had lower final body weights and lower overall relative gains than animals 
treated with either saline or normal sheep serum. Indeed in the high line animals 
injected with normal sheep serum had greater overall relative gains and final weights 
than animals injected with saline (Table 7.4). No significant interaction effects were 
observed (Table 7.4). 
There was no clearly discernible check in the growth of the high line mice after 
any of the injections (Figure 7.5) . However overall the group treated with the 
antiserum to rat-GH appeared to have a lower growth rate. Effects were even less 
clear in the low line, where daily variation in growth rate appeared to be greater 
(Figure 7.6) 
7.5 Discussion 
Sheep antiserum to rat growth hormone appears to have reduced growth in mice. 
The effects of the antiserum on growth appear to have been greatest in the first 
preliminary trial but this may reflect the small sample sizes used in all the trials. Also 
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Table 7.4 





saline normal antiserum 
serum 
Ln(initialwt) 2.517 2.506 2.494 
(mit wt (g)) (12.39) (12.26) (12.11) 
Ln(Final wt) 2.991 2.941 2.908 
(Final wt (g)) (19,91) (18.93) (18.32) 
RG(day 2) 0.036 0.041 0.025 
RG(day 5) 0.060 0.070 0.034 
RG(day 8) 0.126 0.113 0.093 
RG(dayl5) 0.195 0.153 0.132 
RG(day 22) 0.255 0.205 0.172 
Significance Significance Significance S. E. 
line 	treatment interaction means 
effects effects 	effects 













** 	* 	NS 
** 	** 	NS 
High Line 
saline normal antiserum 
serum 
2.895 2.852 2.862 
(18.08) (17.32) (17.50) 
3.593 	3.617 	3.542 
(36.34) (37.22) (34.53) 
0.127 	0.144 0.134 
[IP4:3] 0.326 















Ln, Natural Logarithm 
RG, Relative gain, calculated as the difference between the natural logs 
of the initial weight and the weight on the day stated. 
NS, no significant difference between the groups being compared. 
* P<0.05, ** Pc0.01) 
Figure 7.5 
Mean daily gains of male high P-Line mice from 28 to 35 days old. They recieved 
two injections, at 9am and 5pm on days 1,4 and one injection at 9 am on day 7 
after the start of the experiment, of 1 ljiJ/ g body weight each time. They recieved 
3jsg/ml of antiserum, 3gfml of normal sheep serum or saline. Error bars give 
the maximum standard errors of the means 
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Mean daily gains of male low P-Line mice from 28 to 35 days old. They recieved 
two injections, at 9am and Spin on days 1,4 and one injection at 9 a on day 7 
after the start of the experiment, of 1 lpli/ g body weight each time. They recieved 
3sg/ml of antiserum, 3jsg/ml of normal sheep serum or saline.Error bars give the 
maximum standard errors of the means. 
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the mice used used in the first trial were only 83% P-Line, and it is possible that the 
difference in genotype caused the difference in response to the injected antiserum. 
Low line mice from the backcross did show a reduction in growth rate for the 
duration of the first trial (Figure 7.3) which was not apparent in either of the later 
trials using pure bred P-Line mice. Differences in long term responses to antiserum 
were noted in rats and attributed to differences in ability to remove the foreign 
proteins from the blood (Madon et al, 1991) 
In the final trial no significant interactions between line and treatment effects 
(Table 7.4) were found, which indicated that the lines have shown response to the 
removal of OH in proportion to theft weight, which supports the result of Chapter 6 in 
which no difference between the line in response to the removal of OH by 
backcrossing the little gene into the P-Lines was found. 
It was possible that serum to rat growth hormone would not bind to mouse OH, 
and that the effects observed were non-specific reactions to the sera. The differences 
between the effects of normal sheep serum and the antiserum, in particular the 
increased final weight of high line mice injected with normal sheep serum compared 
to those injected with saline (Table 7.4) do notsupport this. It appears that the sheep 
antiserum to rat growth hormone serum has indeed reduced growth by removing OH, 
the effect is not just due to illness from the large amounts of foreign protein injected. 
Although all conclusions from the chapter must be treated with caution due to the 
small sample sizes used it appears that treatment of growing mice with sheep 
antiserum to rat growth hormone has reduced growth although the magnitude of the 
effect was less than when OH was removed by mutation (Chapters 5 and 6 this thesis, 
Pidduck and Falconer, 1978). The magnitude of the decrease due to the putative 
removal of serum OH was similar to the increase noted when serum OH was elevated 
by the injection of exogenous OH, i.e. approximately 10-15% (Figure 3.2 compared 
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to figures 7.5 and 7.6). The results in combination suggest that direct manipulation of 
serum OH levels is not an effective method of modulating growth rate. The lines do 
not appear to have differed in theft response, which supports the results of the 




Several lines of investigation have been carried out to determine if selection for 
lean mass, or for fat mass, had affected the growth hormone axis. The mice 
investigated were selected on indices similar to those used in livestock, and the 
information obtained may be applicable to such animals. Investigation attempted, 
directly or indirectly, to determine if the levels of growth hormone had altered, and if 
sensitivity to GH had altered. 
8.1 Growth Hormone Treatment in selected lines 
Mice selected for high or low lean mass, and mice selected for high or low fat 
mass all showed an increase in the rate of weight gain over the treatment period, and 
in their final weight after treatment with rbGH, compared to mice injected with 
saline. No significant differences between the lines in the increase relative to initial 
weight were observed (Chapter 3 and 6). This suggests that selection has not altered 
the ability of the lines to respond to exogenous GH, unlike earlier work in other lines 
of mice selected for high and low body size in which differences in growth implied 
that changes in OH metabolism had occurred as a result of selection on growth rate 
(Pidduck and Falconer, 1978). This difference might have been explained by a 
masking effect of endogenous GH in the P-Lines as Pidduck and Falconer, (1978) 
used OH deficient dw mice. However the little gene has been backcmssed into the 
P-Lines, and when OH deficient lit/lit P-Line mice were treated with rbOH they 
responded to exogenous OH in proportion to their body weight (Chapter 6) 
suggesting that there is no difference between the P-Lines in responsiveness to OH. 
This suggests that there have been no effects of selection on GH receptors in the 
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P-Lines. 
Plasma OH concentrations appear to be lower in the mice selected for high body 
weight than in those selected for low body weight at 4, 5, and 7 weeks of age (Tables 
4.4, 4.5). As the lines do not differ in responsiveness to OH wild type (with respect 
to dwarfism) high line mice might have been expected to show a greater response to 
exogenous OH than low line animals. Such a difference was not detected (Chapter 
3), which may indicate no difference or that the difference was too small to be 
detected. Certainly the additional increase of weight gain in response to exogenous 
GH was small compared to the total gain over the same period (10 to 15 percent, 
Chapter 3) and any difference between the lines in response is likely to have a smaller 
effect than this. 
The general increase in tibia bone length in mice treated with rbGH indicates a 
long lasting effect of the OH on growth, as it increased bone growth. Some of the 
greater body weight observed in treated animals may be accounted for by their 
increased bone size and bone weight. Such an increase in bone size would be 
consistent with other studies, for example the greater bone length noted in mice 
transgenic for GH (Wolf et al, 1991). Also long bone length in pubescent humans 
suffering from isolated growth hormone deficiency increased after treatment with GH 
(Tanner et al, 1976). Alternatively the increased weight may have been due to 
carcass components that were not analysed, for example, in sheep a substantial 
increase in non-carcass components of the body, such as skin, fleece and gut has been 
observed after OH treatment (Johnsson a al, 1987). 
Treatment with rbOH did not significantly affect fat content as measured by 
gonadal fat pad percentage and thy weight percentage although there was generally a 
slight decrease. The results in this study may be due to species specificity with rbGH 
not affecting fat percentage in mice. Bovine GH can affect carcass composition, 
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exogenous bGH reduced carcass fat in female lambs (Butler-Hogg and Johnsson, 
1987) so this may reflect a species specific difference. The effects of OH from one 
species can vary across species, for example, ovine OH increased lipolysis in rat, but 
not in ovine, adipose tissue Duquette et al, 1984). 
Taken together the effects on body weight, and on carcass fat suggest that 
responsiveness to exogenous OH has not been affected by selection on lean mass, or 
on total fat. In addition the effects of OH on dwarf little P-Line mice suggest that 
selection on lean mass has not altered responsiveness to OH, which suggests that the 
selection has not altered receptor levels or sensitivity. 
Removal of OH for short periods was attempted by treatment with antiserum to 
OH (Chapter 7), a strategy that had had dramatic effects on growth in rats (Madon et 
al, 1981). This treatment appeared to reduce growth rates more than treatment with 
normal sheep serum, which suggested that the antiserum had reduced plasma levels of 
OH (Table 7.4) although the effects were generally small, similar in magnitude to the 
effects of treatment with exogenous OH. No significant interaction between line and 
treatment effects were noted which suggests that the lines have responded in a 
proportional manner to the treatment, as they did to treatment with OH, again 
suggesting that selection has not altered the response to OH. 
The magnitude of the decrease due to the putative removal of serum OH was 
similar to the increase noted when serum OH was elevated by the injection of 
exogenous OH, i.e. approximately 10-15% (Figure 3.2 compared to figures 7.5 and 
7.6). The results in combination suggest that direct manipulation of serum OH levels 
is not an effective method of modulating growth rate. 
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8.2 Preweaning growth 
The lines of mice differed in weight at birth, which indicated prenatal differences 
in growth. This may be a maternal effect, high line females were two to three times 
the size of low line females (Sharp,et al, 1984, Hastings and Hill, 1989). However 
not only were the high line pups approximately twice the weight of low line pups at 
birth, nearly twice as many were born, on average. Thus the average litter weight of 
high line females was approximately four times that of low line females, which 
suggests the differences may not be entirely due to maternal effects. 
The lines studied here showed similar absolute, not relative, rates of gain over the 
period to 18 days of age (Figures 4.3, 4.4). At this age the rate of gain increased in 
both lines, but the increase was greater for the high line than the low line (Chapter 4). 
Responsiveness to growth hormone begins at approximately 14 days of age in the 
mouse, (Borrelli, et al, 1989). Thus the increase in the rate of gain at 18 days may be 
due to the animals having become responsive to GH and the effect being detectable. 
However this does not explain the greater increase in the high line (Figures 4.3, 4.4, 
and 4.5) which has lower plasma levels of Gil, particularly as an increase in the rate 
of weight gain was also observed in high line GH deficient little mice (Figures 5.6, 
5.7). Low line little mice had a much smaller increase than high line littles and wild 
type low line mice. In both lines the increase in the rate of weight gain was greater in 
the wild type animals than in the little dwarfs (Figures 5.6, 5.7). This suggests that 
the increased rate of weight gain is not primarily due to growth hormone, but to some 
other factor and that GH acts to amplify this effect. 
Mice start to be weaned and eat solid food at approximately 18 days of age 
(Personal observation). It is possible that maternal milk supply may be limiting 
growth before weaning and that the increase in growth rate may be in response to an 
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increased food supply. The crossfostering experiment (Chapter 4) suggests that food 
supply does limit growth before weaning, at least in the low P-Line, but an increase in 
rate of weight gain occurs at 18 days old in low line pups suckled by high line dams 
(Figure 4,3) suggesting that food supply is not the only factor involved. 
This all suggests that some factor other than OH is responsible for the differences 
between the lines, probably some other component of the OH axis such as the insulin 
like growth factors. 
8.3 GH levels 
Plasma GH concentrations appear to be lower in the mice selected for high body 
weight than in those selected for low body weight at 4, 5, and 7 weeks of age (Tables 
4.4, 4.5). This would agree with work in high growth mice which found that they had 
lower levels of plasma OH and higher levels of plasma IOF-I than unselected controls 
(Medrano et al, 1991) and from work in chickens which found that broiler chickens 
had lower plasma OH levels than egg layers (Burke and Marks, 1982). As the lines 
show divergent growth from the point at which they become responsive to OH, and 
this is the age at which IOF-I secretion becomes GH inducible (Mathews, a al, 1988) 
it appears possible that the high P-Line mice have higher levels of bE-I than the low 
line. However work on these lines has already indicated that they do not differ 
significantly in basal IOF-I levels at S weeks old, that is, during the period of rapid 
growth. Basal levels do differ significantly between the lines at 10 weeks of age, 
with the high line having higher IGF-I levels (McKnight and Goddard, 1989). 
Growth in older mice from 4 to 10 weeks of age, appears to show differences 
between the lines (Figure 4.6). It appears that Low line mice have a reduction in the 
rate of gain between 5 and 7 weeks of age which does not occur until later in the high 
line mice. Such a check is not visiblewild  type control animals from 4 to 7 weeks 
128 
old (Figure 3.2). It may be an artifact due to weights only being recorded at 4 points 
during the period from 4 to 10 weeks of age. However it does suggest that selection 
may have altered the length of the growth period, especially when the changes in 
plasma levels of GH and IGF-I with age are considered. 
8.4 Future directions 
The lines differ in body weight at birth. This may be due solely to maternal 
effects, or to a combination of maternal and individual in utero effects. Reciprocal 
crosses between the lines would give pups of identical genotype in different uterine 
environments which should enable separation of maternal and individual effects on 
body weight before and at birth. (This experiment is presently being carried out, 
Guneren and Hastings, personal communication). If no individual effect was 
identified then factors which could only act in utero are less likely to be important in 
differences between the lines; indeed since selection was within family, in utero 
effects common to the whole litter would not be subject to selection. 
Them is evidence for individual in utero differences between the lines. In the 
original replicates, P1, P2, and P3, which were crossed to give the P6 lines (Bootland 
et al, 1991) the high lines had two to three times higher levels of ornithine 
decarboxylase than the low lines at embryonic days 11-13 (Gray, Tait and Bulfield, 
Personal communication). Ornithine decarboxylase is involved in cell growth and 
proliferation, so may be responsible for the differences between the high and low 
P-Lines. Investigation to determine the age at which embryos start to differ in size 
may help determine whether this difference is related to the difference in final body 
weight between the high and low P-Lines. 
IGF-H, which has not been investigated in the P-Lines, is necessary for animals to 
reach normal adult body weight. Mice heterozygous for an IGF-1E1 gene which had 
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been disrupted by homologous recombination were only 60% of the body weight of 
homozygous wild type littermates (Dechiara, Efstratiadis and Robertson, 1990). The 
difference in body weight was observable by embryonic day 16, and appeared to be 
due to effects on the placenta (Dechiara et al, 1990). IGF-I and IGF-ll activities are 
modulated by binding proteins which have been shown, at least for IGF-II, to inhibit 
their activity (McGuire, Jackson et al, 1992)). Thus IGF-H, or growth factor binding 
proteins may be involved in the differences between the lines. Investigation of levels 
of IGF-II in plasma, and various tissues at different stages of embryonic development 
accompanying measures of body size would indicate whether IGF-ll could be 
involved in the differences between the lines. If no differences in IOF-II levels 
between the lines were found but the time at which it were expressed is the same, or 
shortly before, the time at which differences in weight appear, investigation into the 
expression of IOF-il binding proteins may be informative. 
The induction of IGF-I and IOF-H may also have been altered by selection, and 
could be investigated by monitoring plasma levels of these hormones after treatment 
of OH deficient little mice with OH. 
8.5 Conclusion 
OH levels between the lines have been altered by selection, with the high P-Line 
having lower plasma levels of OH than the low line, whether this is due to an increase 
in levels in the low line, a decrease in the high line, or both, cannot be ascertained at 
present. Responsiveness to OH does not appear to have been altered by selection, 
despite this alteration in GH levels. Alterations in GH are clearly not solely 
responsible for the differences between the lines in growth, as shown by the 
differences between the high and low lit/lit mice. Given the differences in body 
weight and litter size at birth it is likely that an important component in the 
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differences between the lines acts before birth. 
Taken together the results presented in this thesis suggest that the dramatic (three 
fold) difference in body weight observed in the P-Lines is not a consequence of large 
scale alterations in OH metabolism. The smaller number of investigations of the 
F-Lines also suggest that the three fold difference in fat content is not due to 
alterations in OH. 
This all suggests that some factor other than OH is responsible for the differences 
between the lines, probably some other component of the OH axis such as the insulin 
like growth factors. It is therefore anticipated that future work on these lines will 
investigate the mediators of OH activity such as IGF-I, IOF-11 and the IOF binding 
proteins. Also given the difference in weights at birth it is suggested that regulation 
of in utero growth would reward further study. 
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ABSTRACT 
The effects of exogenous GM on growth and body 
composition were investigated in lines of mice selected 
for high or low body weight (P-lines) or high or low 
body fat (F-lines). Mice from all lines were given daily 
injections of recombinant bovine GM or a placebo for 
21 days from 4 weeks old. They were killed and vari-
ous organ weights measured. There was no consistent 
effect of GH on organ weights. In all lines of mice 
the rate of weight gain and final weight increased in 
response to GM. In both lines selected for body fat, 
GM treatment decreased fat content. The low body 
weight mice also became less fat, but in the high body 
weight mice GM treatment increased fat percentage. 
The results indicate that the differences in growth rate 
and body composition observed in these lines are not 
due to differences in responsiveness to GM. 
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INTRODUCTION 
Investigations of the role of growth hormone (GM) in 
the differences between genetic lines of animals differ-
ing in body weight, lean mass or rate of growth have 
produced conflicting observations. Broiler lines of 
chickens selected for faster growth rate have lower 
plasma levels of GM than slower growing layer lines 
(Burke & Marks, 1982; Stewart & Washburn, 1983). 
An experiment in which the Snell Dwarf gene was 
backcrossed into strains of mice selected for large and 
small size, thereby depleting them of endogenous GM, 
showed that GM was only partially responsible for 
differences in growth rate and that the smaller mice 
had reduced sensitivity to GH (Pidduck & Falconer, 
1978). In addition, studies on a variety of species indi-
cate that the relationship, within species, between 
endogenous levels of OH and several growth par-
ameters is poor (Hart & Johnsson, 1986). There is, 
however, some evidence that larger breeds of cattle 
have increased levels of OH (Hart & Johnsson, 1986). 
Experiments involving OH treatment in a number 
of species have produced a variety of results. Treat-
ment of pigs with recombinant DNA-derived human 
GM (Baile, Della-Fera & McLaughlin, 1983) or with 
pituitary-derived porcine OH (Chung, Etherton & 
Wiggins, 1985; McLaren, Easter, Novakofski et al.  
1988) increased growth rate. In lambs some studies 
have shown an effect on weight gain after treatment 
with pituitary bovine GH (Johnsson, Hart & Butler-
Hogg, 1985) or with recombinant bovine GH (rbGH) 
(Pullar, Johnsson & Chadwick, 1986). However, other 
studies by the same group and others found no sig-
nificant effect of rbGM on growth rates (Johnsson, 
Mathorn, Wilde eral. 1987; Sinnett-Smith, Woolliams, 
Warriss & Enser, 1989). Similarly, treatmentwith ovine 
GM did not significantly affect weight gain in lambs 
(Muir, Wein, Duquette et al. 1983). These studies indi-
cate that while changes in plasma GM may be correlated 
with increased size and growth rate of some genetically 
different lines, it is probably not the only growth factor 
involved. 
Investigations into effects of GM on carcass com-
position have consistently shown a reduction in the 
proportion of fat in the carcass. This has been demon-
strated using porcine GH in pigs (Chung et al. 1985; 
Novakofski, McKeith, Grebner et at 1988) although 
the weight of fat is not always decreased (Chung etal. 
1985). A study using human GM in pigs, however, 
found no significant effect on body fat (Baile et al. 
1983). All studies in lambs have shown a reduction in 
carcass fat in GM-treated animals as compared with 
controls (Wagner & Veenhuizen, 1978; Muir et al. 
1983; Johnsson et at 1985, 1987; Pullar et at 1986; 
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Butler-Hogg & Johnsson, 1987; Sinnett-Smith et al. 
1989). 
Treatment of pigs with porcine GH increased carcass 
protein (Chung et at 1985), and in a study using bovine 
GH in lambs, significant increases were obtained in 
muscle mass after treatment (Butler-Hogg & Johnsson, 
1987), whereas another study using intact male lambs 
showed no significant increase in the proportion ofpro-
tein in the carcass after bovine GH treatment despite a 
significant increase in growth rate (Pullar et al. 1986). 
Others have found only a small effect on muscle gain 
in lambs (Muir et at 1983; Johnsson et al. 1987). 
These results indicate that effects of GH on body 
composition are likely to be greater than on body 
weight and rates of weight gain. Consequently any 
differences between divergent stocks in responsiveness 
to GH are more likely to affect composition. In this 
study we have investigated the effects of rbGH on 
growth differences in lines of mice selected for differ-
ences in growth and body composition. The selected 
lines of mice in this study differ by a factor of 15 in 
body weight at 10 weeks (P-lines), or by a factor of 25 
in gonadal fat pad weight as a proportion of body 
weight at 10 weeks (F-lines) (Hastings & Hill, 1989). 
MATERIALS AND METHODS 
Animals 
The mice were taken from lines established in 1980 
(Sharp, Hill & Robertson, 1984). Mice were drawn 
from a common base population to give three repli-
cates of each of three selection treatments: high, low 
and control for each selected trait. Selection was 
within litter on 10-week-old males. The F-line was 
selected on the ratio of gonadal fat pad weight to body 
weight; the P-line on fat-free mass predicted from body 
weight and gonadal fat pad weight (Sharp etal. 1984). In 
generation 20 the selection criteria were modified such 
that the P-lines were selected on 10-week weight in both 
sexes and the F-lines were selected on the ratio of dry to 
wet weight in 14-week-old males. The three replicates of 
each direction were crossed at this stage to give a single, 
unreplicated line with lower inbreeding. The mice used 
were the offspring of mice from generation 12 (F-line) 
or 13 (P-line) after the cross, i.e. after a total of 32 or 
33 generations of selection respectively. 
The animals were kept in controlled light conditions 
(14 h light: 10 It darkness) from weaning at 3 weeks 
until the end of the treatment period. They were given 
free access to BP expanded mouse diet number 1 food 
(Special Diet Services, Witham, Essex, U.K.), with the 
same food available as mash until the smallest mouse in 
a cage reached 10 gin weight. Only males were used, to 
avoid the confounding effects of sex-based differences. 
The F- and P-lines were non-contemporaneous. 
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Experimental design and treatments 
Mice were assigned randomly within family to the 
control or treatment group when weaned at 21 (±2) 
days. Treatment commenced 7 days later in order to 
reduce maternal influences, the major source of vari-
ability in weight at weaning (Eisen, 1974). Animals 
were treated daily from 4 to 7 weeks of age with rbGH 
(kindly donated by the American Cyanamid Co., 
Princeton, NJ, U.S.A.) at 9 ig/g body weight per day 
given as US mg/ml sterile solution prepared in isotonic 
bicarbonate buffer (pH 94) or with a saline placebo 
(0 1 ml/20 g body .weight). Injections were given s.c. 
within the 2 h before the start of the dark period and 
the mice were weighed immediately before injection. 
On day 21 after the treatment started the mice were 
weighed and then killed by cervical dislocation. The 
liver, spleen, kidneys, gonadal fat pad (GFP) and pec-
toralis muscle were dissected out and weighed. These 
components were then restored to the carcass which was 
freeze-dried and weighed. Finally the hind legs were 
taken and boiled to remove the flesh, enabling tibia 
length to be measured. The length did not include the 
terminal epiphyses. 
In a preliminary experiment (not shown), the 
growth-promoting ability of rbGH was confirmed in 
OH-deficient Little (hi/lit) mice which lack circulating 
GH and respond to GH treatment by increased 
growth (Beamer & Eicher, 1976). 
Statistical analysis 
The results were analysed using a mixed model least 
squares and maximum likelihood computer program 
(Harvey, 1985). Analyses were carried out using a 
model with line and treatment as fixed cross-classified 
effects. Family was included as a random effect, 
nested within line. The model also tested for inter-
actions between line and treatment. All analyses used 
natural logarithms of weight to remove scaling effects 
due to the substantial difference in size between the 
high and low selected P-line mice. Traits, other than 
initial weight, were also regressed on the natural log of 
initial weight to remove the effects of initial body 
weight differences between animals. This regression 
reduced the S.EM. values in the analyses (log final 
weight showed a correlation with initial weight of over 
080 for all lines other than the one selected for high 
body fat, in which the correlation exceeded 065). 
Relative gain was also analysed as its logarithm, cal-
culated for each animal as natural log of final weight 
minus natural log of initial weight. 
RESULTS 
All the lines of mice in this study responded to rbGH 
by increasing their growth rate (Tables 1 and 2). 
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TABLE 1. Body weights of mice selected for high and low body fat content (F-lines). Male mice from the fat and lean lines were 
injected daily from 4 to  weeks of age with 9 sg recombinant bovine GH (rbGH)/g body weight per day, or with 0 1 ml saline/ 
20 g body weight per day. Organ weights are as a percentage of final body weight. All traits other than initial weight were 
regressed on Ln (initial weight) 
Fat Lean 
Significance Significance 
Saline OH Saline OH 	treatment line 5.E.M 
No. of animals 18 Il 18 18 
Ln (body weight (g)) 294 289 293 284 	
* NS ±0084 
at 4 weeks 
(initial body wt (g)) (189) (180) (185) (169) ±(1- 09 
Ln (body weight (g)) 139 147 332 140 	** ±0017 
at 7 weeks 
(final body wt (g)) (297) (320) (270) (30-2) ±( I -02) 
RO (overall) 049 0-57 042 0-51 	** ±0017 
Ln. natural logarithm; RO, relative gain, calculated as the difference between the natural logs of the initial and final weights of the period in question. NS, no 
significant difference between the groups being compared. 'P<0 05, "P<0 01 for linear treatment effects (the data were analysed by analysis of vanance with a 
mixed model least squares and maximum likelihood computer program (Haney, 1985)). 
TABLE 2. Body weights of mice selected for high and low whole body weight (P-lines). Male mice were injected daily from 4 to 7 
weeks of age with 9 sg recombinant bovine GH (rbGH)/g body weight per day, or with Oi ml saline/20 g body weight per day. 
All traits other than initial weight were regressed on La (initial weight) 
High Low 
Significance Significance Significance 
Saline OH Saline OH treatment line interaction S.E.M. 
No. of animals 30 30 30 30 
Ln (body weight (g)) 313 313 2-68 253 * ** ±0-067 
at 4 weeks 
(initial wt (g)) (229) (229) (146) (126) (± 1-07) 
Ln (body weight (g)) 3-63 371 316 323 " ** NS ±0021 
at 7 weeks 
(final body wt (g)) (381) (400) (236) (253) (± 1-02) 
RG(overall) 083 090 033 040 NS ±0049 
Ln, natural logarithm; RO, relative gain calculated as the difference between the natural logs of the initial and final weights of the period in question. 
NS, no significant difference between the groups being compared. FcO'05. "P -c 0-01 for line or treatment effects (the data were analysed by analysis of variance 
with a mixed model least squares and maximum likelihood computer program (Harvey. 1985)). 
At 4 weeks of age, before treatment, there was no 
significant difference in body weight between the lines 
selected for high and low fat content (F-lines) (Table I). 
Mice selected for high fat had a final weight 1-14 times 
that of the lean line. The line selected for high body 
weight was significantly (P < 0-0 1) heavier, byabout9 g, 
than the line selected for low body weight, irrespective 
of treatment, and gained twice as much weight over 
the test period (Table 2). Averaged over both fat lines, 
the gain of the treated mice was a factor of 1-9 (3-4 g) 
greater than that of the untreated mice. Averaged over 
both body weight lines the gain of the treated mice 
was a factor of 1-15 greater than that of the untreated 
mice. There is an apparent discrepancy between the 
values of the relative gain in Tables I and 2, and that 
calculated from the initial and final weights given. 
This is a consequence of the different correction fac-
tors applied to relative gain, and to final weight, by  
their regression on initial weight. The discrepancy is 
greater in the body weight lines due to the greater 
difference in weight between these lines. 
In all lines it appeared that the rbOH had caused 
the maximal rate of weight gain to be maintained for a 
longer period than in untreated mice, resulting in 
greater weight gain over the whole period, and greater 
final weights. Gonadal fat pad and dry matter per-
centages are indicators of the amount of fat in the 
carcass (see Materials and Methods). Both were sig-
nificantly (PcOOl) greater in the high fat line than in 
the low fat line (Table 3). Gonadal fat pads were pro-
portionately smaller in the high P-line mice (P<001) 
(Table 4). This may be due to the original selection 
criterion being fat-free mass, predicted from gonadal 
fat pad weight and body weight. Treatment with 
rbGI-1 had no significant effect on gonadal fat pad 
weight as a percentage of body weight in any line or 
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TABLE 3. Organ weights of mice selected for high and low body fat content (F-lines). Male mice from the fat and lean lines were 
injected daily from 4 to 7 weeks of age with 9 sg recombinant bovine OF! (rbGH)/g body weight per day, or with 0- 1 ml saline/ 
20 g body weight per day. Organ weights are expressed as a percentage of final body weight. All traits other than initial weight 
were regressed on Ln (initial weight) 
Fat 	 Lean 
Significance 	Significance 	Significance 
Saline 	OH 	Saline 	OH 	treatment line 	 interaction 	S-tM. 
Gonadal fat pad 109 1-06 041 0-36 NS NS ±0044 
(% body weight) 
Dry body weight 38-6 37-9 318 299 * U MS ±0-62 
(% wet body weight) 
Pectoralis muscle 035 0-29 0-30 038 NS NS ** ±0-017 
(% body weight) 
Tibia bone length 16-5 16-6 16-6 16-8 NS NS NS ±0 - 10 
(mm) 
Liver weight 55 5-5 5-4 5-2 NS NS MS ±0-12 
(% body weight) 
Kidney weight 1-43 1-37 1-58 153 * U MS ±0042 
(% body weight) 
Spleen weight 031 032 040 041 NS * NS ±0 - 027 
(% body weight) 
Ln, natural logarithm: RG, relative gain, calculated as the difference between the natural logs of the initial and final weights of the period in question. 
NS, no significant difference between the groups being compared. -P<0 - 05, "P<0 01 for line or treatment effects (the data were analysed by analysis of variance 
with a mixed model least squares and maximum likelihood computer program (Harvey, 1985)). 
TABLE 4. Organ weights of mice selected for high and low body weight (P-lines). Male mice were injected daily from 4 to 7 
weeks of age with 9 sg recombinant bovine GH (rbGH)/g body weight per day, or with 0-I ml saline/20 g body weight per day. 
Organ weights are expressed as a percentage of final body weight. All traits other than initial weight were regressed on Ln 
(initial weight). 
Hiah 	 Low 
Significance Significance Significance 
Saline OH Saline OH treatment line interaction SLIM. 
Gonadal rat pad 047 050 095 0-86 NS " NS ±0-088 
(% body weight) 
Dry body weight 33-I 360 360 35-2 NS NS NS ±163 
(% wet body weight) 
Pectoralis muscle 0-36 0-35 034 034 NS NS NS ±0028 
(% body weight) 
Tibia bone length 172 17-6 15-8 16-0 NS ** NS ±0-23 
(mm) 
Liver weight 58 55 54 53 NS NS NS ±017 
(% body weight) 
Kidney weight 147 138 1-55 1-49 • MS MS ±0069 
(% body weight) 
Spleen weight 0-38 0-44 022 021 NS ** * ±0023 
(% body weight) - 
Ln. natural logarithm; RO, relative gain calculated as the difference between the natural logs of the initial and final weights of the period in question. 
NS, no significant difference between the groups being compared. PcO-05, "Pc0-0l for line or treatment effects (the data were analysed by analysis of variance 
with a mixed model least squares and maximum likelihood computer program (Harvey, 1985)) 
on dry weight as a percentage of body weight in the 
body weight lines (Tables 3 and 4). There was a sig-
nificant reduction of dry weight as a percentage of 
body weight in the rbGH-treated fat lines. When all 
four lines were analysed together there was a significant 
(P <0-05) line-by-treatment interaction for dry weight 
percentage. This suggests a between-line difference in 
the involvement of OH in fat regulation. 
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The pectoralis was chosen as an easily dissected 
muscle which could be used to estimate the effects of 
OH on muscle mass. GH treatment did not affect pec-
toralis weight as a percentage of final weight in the 
lines selected for body weight (Table 4). OH treatment 
reduced pectoralis weight asa percentage of final weight 
in the high fat mice but increased it in the low fat mice 
(Table 2). This was apparent as a significant line-by- 
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treatment interaction (P <0-05), and suggests that 
selection in the high fat mice has altered the interaction 
of OH with metabolism. 
The high body weight line had a significantly 
(PcOOl) greater tibia length than the low body 
weight line (Table 4). Tibia length was consistently, 
but not significantly, greater in treated animals than in 
the control group in each of the four lines of mice 
(Tables 3 and 4). 
There were no significant line or treatment effects 
on liver weight as a percentage of body weight. The 
significant (P <0.05) reduction in kidney weight as a 
percentage of body weight (Tables 3 and 4) after treat-
ment implies that the kidney is less susceptible to GH 
than other tissues. This may be due to kidneys reaching 
their final size before the rest of the body. A significant 
(P < 005) difference in spleen weight as a percentage of 
body weight between lines was noted in these exper-
iments, as was a significant (Ptz0.05) interaction 
between line and treatment in the body weight lines 
(Tables 3 and 4). Previous studies have shown that 
spleen size and shape vary considerably between inbred 
strains (Dunn, 1954). This suggests that the differences 
may be due to drift following the long separation of 
the lines. No pathological changes were noted. 
DISCUSSION 
Treatment with OH increased the rate of weight gain 
and final weight in mice of all lines. The similarity of 
the response between lines in terms of the increase of 
weight gain and final weight relative to initial weight 
suggest that selection has not altered the ability to 
respond to GE. The effect of selection on response to 
GH might have been expected to be greatest in the 
lines selected for high and low body weight. Studies in 
other lines of mice selected for high and low body size 
indicated that the mice selected for smaller size were 
also less responsive to OH (Pidduck & Falconer, 
1978). However, other research has shown that OH 
often does not show obvious correlations with differ-
ences in rates of weight gain and body size. Broiler 
chickens have lower levels of plasma OH than slower 
growing layer lines (Burke & Marks, 1982; Stewart & 
Washburn, 1983). 
Assigning mice by weight within family to treat-
ment group would have prevented the occurrence of 
significantly lower weights in the mice assigned to the 
treatment group in the low body weight and low body 
fat lines (Tables 1 and 2). However, the problem was 
not observed until the start of the treatment. Carcass 
analysis of 4-week-old mice would also have been use-
ful in giving a base line to which comparisons could be 
referred. This was prevented by limitations in the 
number of mice available. 
The general increase in tibia bone length in mice 
treated with rbGH indicates a long-lasting effect of 
GH on growth, following increased skeletal size. 
Some of the greater body weight observed in treated 
animals may be accounted for by their increased bone 
size and bone weight. In sheep a substantial increase 
in non-carcass components of the body, such as skin, 
fleece and gut, was observed after OH treatment 
(Johnsson et at 1987). Skin and gut may account for 
part of the greater weight observed in these treated 
mice. 
Treatment with rbGH did not consistently affect fat 
content as measured by gonadal fat pad weight as a 
percentage of body weight and dry weight as a per-
centage of body weight although there was generally a 
slight decrease. There may be species specificity with 
rbGH having a lesser effect on fat deposition in mice 
than it does in lambs. Similarly human OH had no 
significant effect in pigs (Baile et at 1983). It might 
have been expected that the fat mice, having the 
greatest fat content, would have shown the greatest 
reduction in body fat after treatment with rbGH but 
this was not the case. This may be due to the limited 
effects on fat observed in this study. 
The principal conclusion from these experiments is 
that mice from all the lines studied respond to treatment 
with rbGH by gaining weight faster. This growth is not 
solely due to an increased rate of gain of protein, as 
indicated by the relative size of the pectoralis muscle, 
and is probably due to greater growth of the bones, gut 
and skin. As the lines reacted very similarly in terms of 
increase of final weight relative to initial weight, and of 
gain relative to initial weight it can be concluded that 
there is no difference between them in their response to 
exogenous OH. The mice also showed some evidence of 
a reduction in fat after treatment, which supports pre-
vious work showing that exogenous OH improves 
carcass quality by reducing fat percentage. It appears 
therefore that the differences in growth rate observed 
in these lines are possibly not due to differences in 
responsiveness to OH. Any involvement of OH in 
these genetic differences may He in differences in 
synthesis or secretion. 
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PRODUCTION OF HIGH AND LOW BODY WEIGHT lit/lit DWARVES 
L H. Bootland, W. C. Hill and I. M. Hastings. Institute of Cell. Animal and Population 
Biology, University of Edinburgh. West Mains Road, Edinburgh. 
Lines for high and, low body weight were established to investigate the 
consequences of selection on fat free body mass, (P-Lines) (1). After 20 generations 
the initial replicates were crossed and selection changed to 10 week weight in both 
sexes (2). At the start of this experiment 34 generations of selection had been carried 
out in total and adult body weight in the high line was about twice that in the low 
line. 
As pan of an investigation into the involvement of growth hormone (GH) in the 
differences between the P-Lines lit dwarfism was backcrossed into them. lit/lit 
dwarves on a C57BLJJ background were mated to unselected mice from the lines. 
Test matings were carried out in each generation to ensure that the lit gene was 
being propagated. Three generations of backcrossiflg have been carried out giving a 
background which is 93% P-Line on average. The backcrossing program is continuing. 
lit/lit dwarves which differ in body size might be useful for studies into growth. 
Effects on body weights of males from birth to 6 weeks of age can be seen below. 
Clearly GH is not the sole factor in the difference between the high and low P-Lines. 
This accords with the results of backcrossing dwdwarfisni, which has greater pituitar'/ 
effects than lit into the lines selected to diverge in growth rate (3). 
y =Low line lit/lit, n4, semO.Si 
A= High line lit/lit, n10, eem0.72 
x = Low line wild hype, n=74, aem O.22 
• = High line wildtype, n63, eem0.67 
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